Fungicidal composition

Abstract

The present invention relates to a fungicidal composition comprising components (A) and (B), wherein components (A) and (B) are as defined in claim 1; and the use of the composition in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi.

Description

[0001] This invention relates to novel antifungal compositions, their use in agriculture or horticulture for controlling diseases caused by plant pathogens (especially plant pathogenic fungi and more particularly oomycetes), and methods for controlling diseases on beneficial plants.

[0002] Although many fungicidal compounds and compositions belonging to various chemical classes have been developed or are being developed for use as fungicides in beneficial plant crops, crop tolerance and activity against specific plant pathogens do not always meet the needs of agricultural practice in many respects. Therefore, there is a persistent need to discover new compounds and compositions with superior biological properties for the control or prevention of plant infection by plant pathogens. For example, compounds with greater biological activity, favorable activity spectra, increased safety, improved physicochemical properties, or increased biodegradability. Or, alternatively, compositions with broader activity spectra, improved crop tolerance, improved synergistic interactions, or enhancing properties, or compositions exhibiting faster onset of action or longer residual activity, or compositions that reduce the number of applications and / or application rate required for effective control of plant pathogens, thereby enabling beneficial tolerance management practices, reducing environmental impact, and reducing operator exposure.

[0003] Some of these needs can be addressed by using compositions comprising mixtures of different fungicidal compounds with different modes of action (e.g., by combining fungicides with different activity spectra).

[0004] According to the present invention, an antifungal composition is provided, the antifungal composition comprising components (A) and (B) as active ingredients, wherein component (A) is a compound having formula (I):

[0005]

[0006] Where Z is O;

[0007] R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6Alkyl and C 3-6 cycloalkyl-C 1-4 Each of the alkyl groups is optionally substituted with CN;

[0008] R 2a Selected from H, C 1-6 Alkyl, C 3-6 cycloalkyl and C 1-6 Alkoxy-C 1-6 alkyl;

[0009] R 2b Selected from H, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 alkyl;

[0010] R 2c It is H;

[0011] J is N or CR 4 ;

[0012] G is CR 5 ;

[0013] R 3 It is H;

[0014] R 4 It is halogen or CN;

[0015] R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy groups and halogens;

[0016] A is CH or N; and

[0017] R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino, C 1-6 alkoxyamino and C 1-6 Alkyl C 1-6 Alkoxyamino;

[0018] Or its salts or N-oxides;

[0019] and

[0020] Component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, Bacillus amyloliquefaciens, benzovindiflubenzuron, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluopyram, fluoxazinamide, captan, emetolide, indoxazinamide, styraclostrobin, isofennoquine, isofennoquine Oxalide, isopyram, isothiazamide, dicytylosin, chlorfluazuron, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxetine, fluoxetine aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxetine hydroxylamine, azoxystrobin, quinoline, fluoxetine, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, trifluralin, benzoyl methoxycarb, benzoyl methoxycarb, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide [-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl [(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide.

[0021] In a specific embodiment of the invention, component (A) is a compound having formula (I):

[0022]

[0023] Where Z is O;

[0024] R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Each of the alkyl groups is optionally substituted with CN;

[0025] R 2a Selected from H, C 1-6 Alkyl, C 3-6 cycloalkyl and C 1-6 Alkoxy-C 1-6 alkyl;

[0026] R 2b Selected from H, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 alkyl;

[0027] R 2c It is H;

[0028] J is CR 4 ;

[0029] G is CR 5 ;

[0030] R 3 It is H;

[0031] R 4 It is halogen or CN;

[0032] R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy groups and halogens;

[0033] A is CH or N; and

[0034] R 6 Selected from C1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino, C 1-6 alkoxyamino and C 1-6 Alkyl C 1-6 Alkoxyamino;

[0035] Or its salts or N-oxides.

[0036] In another specific embodiment of the invention, component (A) is a compound having formula (I);

[0037]

[0038] Where Z is O;

[0039] R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Each of the alkyl groups is optionally substituted with CN;

[0040] R 2a Selected from H, C 1-6 Alkyl, C 3-6 cycloalkyl and C 1-6 Alkoxy-C 1-6 alkyl;

[0041] R 2b Selected from H, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 alkyl;

[0042] R 2c It is H;

[0043] J is N;

[0044] G is CR5 ;

[0045] R 3 It is H;

[0046] R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy groups and halogens;

[0047] A is CH or N; and

[0048] R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino, C 1-6 alkoxyamino and C 1-6 Alkyl C 1-6 Alkoxyamino;

[0049] Or its salts or N-oxides.

[0050] In this invention, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline- 3-Formamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide Amines, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide can be derived from WO4. Prepared by the method described in 2017 / 153380.

[0051] In this invention, the amide selected from N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 [(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl] [-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N Of the components of -((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, the preferred compound (compound Z) is the compound having the following CAS number: 2132414-04-9 (feneptamidoquin). Compound Z is more particularly a compound containing 80%-100% of the R-enantiomer of N-[(1RS)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide.

[0052] In this invention, *Streptomyces commune* comprises a nucleotide sequence having at least 99.8%, preferably at least 99.9%, preferably at least 99.91%, 99.92%, 99.93%, 99.94%, 99.95%, 99.96%, 99.97%, 99.98%, or 99.99% identity with SEQ ID NO:1. In a specific embodiment, *Streptomyces commune* comprises a nucleotide sequence having 100% identity with SEQ ID NO:1. SEQ ID NO:1 comprises the 16S RNA gene of *Streptomyces commune* Saigon 413, deposited at the Fungal Culture Collection Center with accession number CBS149411.

[0053] Throughout this document, the term "composition" refers to different mixtures or combinations of components (A) and (B) (including the embodiments defined above), for example, in a single "ready-to-use with water" form, as a combined spray mixture (consisting of individual formulations of these single active ingredient components) (e.g., a "tank mix"), and as a combination of these single active ingredients when applied in a sequential manner (i.e., one after the other within a suitable short period, such as hours or days). For the purposes of this invention, the order in which components (A) and (B) are applied is not critical.

[0054] The term "halogen" refers to fluorine (fluoro or F), chlorine (chloro or Cl), bromine (bromo or Br), or iodine (iodo or I), with fluorine or chlorine being preferred.

[0055] The term "amino" refers to the -NH2 group.

[0056] As used herein, the term "alkyl" (in isolation or as part of a chemical group) refers to a straight-chain or branched hydrocarbon, preferably having 1 to 6 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,2-dimethylpropyl, 1,3-dimethylbutyl, 1,4-dimethylbutyl, 2,3-dimethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl, and 2-ethylbutyl. Alkyl groups having 1 to 4 carbon atoms are preferred, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, or tert-butyl.

[0057] The term "cycloalkyl" (in isolation or as part of a chemical group) refers to a saturated or partially unsaturated monocyclic, bicyclic, or tricyclic hydrocarbon, preferably having 3 to 10 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl, or adamantyl. Cycloalkyl groups having 3, 4, 5, 6, or 7 carbon atoms are preferred, such as cyclopropyl or cyclobutyl.

[0058] The term "alkoxy" refers to an alkoxy group having the formula -OR a The group, wherein R aAlkoxy groups are alkyl groups as generally defined above. Examples of alkoxy groups include, but are not limited to, methoxy, ethoxy, propoxy, isopropoxy, and tert-butoxy. The term "alkoxyalkyl" refers to an alkyl group substituted with the alkoxy group (as mentioned above). Examples are methoxymethyl, methoxyethyl, ethoxymethyl, and propoxymethyl.

[0059] The term "alkylamino" refers to an amino group having the formula R a NH- groups, where R a It is an alkyl group as generally defined above.

[0060] The term "alkoxyamino" refers to an amino group having the formula R a NH- groups, where R a It is an alkoxy group as generally defined above.

[0061] The term "alkylsulfonyl" refers to an alkyl group having the formula -S(O)2R a The group, wherein R a It is an alkyl group as generally defined above.

[0062] In this invention, the weight ratio of component (A) to component (B) can preferably be from 100:1 to 1:100, from 50:1 to 1:50, from 20:1 to 1:40, from 15:1 to 1:30, from 12:1 to 1:25, from 10:1 to 1:20, from 5:1 to 1:15, from 3:1 to 1:10, or from 2:1 to 1:5.

[0063] In addition, according to the present invention, a method for controlling or preventing plant pathogenic diseases, especially plant pathogenic fungi, on useful plants or their propagation material is provided, the method comprising applying a fungicidal composition according to the present invention to such useful plants, their sites or their propagation material.

[0064] The benefits provided by certain fungicidal mixture compositions according to the invention may also include, in particular, favorable levels of bioactivity for protecting plants against fungal diseases or superior properties for use as an agrochemical active ingredient (e.g., greater bioactivity, favorable activity spectrum, increased safety, improved physicochemical properties, or increased biodegradability).

[0065] In each case, the compound having formula (I) according to the invention is in a free form, in an oxidized form (such as an N-oxide) or in a salt form (e.g., in the form of an agronomically available salt).

[0066] N-oxides are the oxidized forms of tertiary amines or nitrogen-containing heteroaromatic compounds. For example, they are described by A. Albini and S. Pietra in their 1991 book, "Heterocyclic N-oxides," published by CRC Press in Boca Raton.

[0067] For compounds having formula (I) with substituent R 1 R 2a R 2b R 2c R 3 R 3 R 4 R 5 A and R 6 The preferred groups and values, and any combination thereof, are listed below:

[0068] -R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 alkylsulfonyl-C 1-6 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 alkylsulfonyl-C 1-6 Each of the alkyl groups is optionally substituted with CN, and is preferably selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3 and CH2CN;

[0069] -R 2a Selected from H and C 1-6 Alkyl groups, and preferably selected from H and CH3;

[0070] -R 2b Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 Alkyl groups, and preferably selected from H, CH3, -CH2OCH3, -NH2 and -NHC(O)CH3;

[0071] -R 2c It is H;

[0072] -J is N or CR 4 ;

[0073] -G is CR 5 ;

[0074] -R 3 It is H;

[0075] -R 4 It is halogen or CN, and preferably chlorine, fluorine, or CN;

[0076] -R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkyl groups and halogens, and preferably selected from H, CH3, -OCH3 and fluorine;

[0077] -A is CH or N; and

[0078] -R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino and C 1-6 Alkoxyamino groups, and preferably selected from cyclopropyl, -OCH3 and -NH-O-CH3;

[0079] Or its salts or N-oxides.

[0080] In the most preferred embodiment of the invention, any combination of compounds of formula (I) is as follows:

[0081] -R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 alkylsulfonyl-C 1-6 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 alkylsulfonyl-C 1-6 Each of the alkyl groups is optionally substituted with CN, and is preferably selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3 and CH2CN;

[0082] -R 2a Selected from H and C 1-6 Alkyl groups, and preferably selected from H and CH3;

[0083] -R 2b Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6Alkyl groups, and preferably selected from H, CH3, -CH2OCH3, -NH2 and -NHC(O)CH3;

[0084] -R 2c It is H;

[0085] -J is CR 4 ;

[0086] -G is CR 5 ;

[0087] -R 3 It is H;

[0088] -R 4 It is halogen or CN, and preferably chlorine, fluorine, or CN;

[0089] -R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkyl groups and halogens, and preferably selected from H, CH3, -OCH3 and fluorine;

[0090] -A is CH or N; and

[0091] -R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino and C 1-6 Alkoxyamino groups, and preferably selected from cyclopropyl, -OCH3 and -NH-O-CH3;

[0092] Or its salts or N-oxides.

[0093] In another most preferred embodiment of the invention, any combination of compounds of formula (I) is as follows:

[0094] -R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 alkylsulfonyl-C 1-6 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 alkylsulfonyl-C 1-6 Each of the alkyl groups is optionally substituted with CN, and is preferably selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3 and CH2CN;

[0095] -R2a Selected from H and C 1-6 Alkyl groups, and preferably selected from H and CH3;

[0096] -R 2b Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 Alkyl groups, and preferably selected from H, CH3, -CH2OCH3, -NH2 and -NHC(O)CH3;

[0097] -R 2c It is H;

[0098] -J is N;

[0099] -G is CR 5 ;

[0100] -R 3 It is H;

[0101] -R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkyl groups and halogens, and preferably selected from H, CH3, -OCH3 and fluorine;

[0102] -A is CH or N; and

[0103] -R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino and C 1-6 Alkoxyamino groups, and preferably selected from cyclopropyl, -OCH3 and -NH-O-CH3;

[0104] Or its salts or N-oxides.

[0105] Most preferably, component (A) is a compound selected from compound numbers X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.16, X.17, X.18, X.19, X.20, X.21, X.22, and X.23 as defined in Table X below. More preferably, component (A) is a compound selected from compound numbers X.01, X.02, X.03, X.04, X.05, X.06, X.21, X.22, and X.23 as defined in Table X below.

[0106] Table X

[0107]

[0108]

[0109]

[0110] Preferably, component (B) is a compound selected from the group consisting of: aramacin-type benzyl-S-methyl, azoxystrobin, indoxazole-sulfuron, azoxystrobin, chlorothalonil, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam, fluoxastrobin, streptomycin, benzyl amide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide and N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide.

[0111] More preferably, component (B) is a compound selected from the group consisting of: aramacin-benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridamole, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluopyram, fluoxastrobin, streptomycin, benzoyl sulfadiazine, and compound Z (feneptamidoquin).

[0112] These component (B) compounds are referred to herein and above by their so-called "ISO common name" or another "common name" or trademark name, as used in individual cases. These component (B) compounds are known and commercially available and / or can be prepared using procedures known in the art and / or procedures reported in the literature.

[0113] In a preferred composition according to the invention, component (A) is compound number X.01[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0114] In another preferred composition according to the invention, component (A) is compound number X.02[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, cyazofamid, triflupyridamole, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0115] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.03[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide Cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazolium, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphonates, tetrazolium pyridaben, prothioconazole, fluoxazinamide, azoxystrobin, quinoline, fluoxazinium bromide Amine, thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N- [(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0116] In another preferred composition according to the invention, component (A) is compound number X.04[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fludioxonil, fludioxonil, fluopyram, fluopyram, Fluopyram, fluoxazin, fluopyram, fluoxazinamide, fluoxazinamide, captan, emamectin, indexpyram, styrazinazole, isofennoquine, isoxazinamide, isopyram, isothiazinamide, isothiazinamide, diyrylamide, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxazinamide, fluoxazinamide, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, trifluralin, styrazinamide, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3- Formamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl The following are listed: [-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0117] In another preferred composition according to the invention, component (A) is compound number X.05[N-[4-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam Fluoxadiazon, fluopyram, fluoxadiazonamide, fluoxadiazonamide, captan, emamectin, indapoxetine, styrazinazole, isofennoquine, isoxadiazonamide, isopyram, isothiazonamide, dimethomorph, chlorfluazon, metalaxyl, metalaxyl-M (metalaxyl), methyltetraproline, fluoxadiazon, fluoxadiazon aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadiazonyl hydroxylamine, pyraclostrobin, quinoline, fluoxadiazonamide, thiophanate-methyl, streptomycin, tebuconazole, flufenoxuronamide, thiamethoxam, triflumethoprim, benzoyl benzoate, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl The following are listed: [1S]-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0118] In another preferred composition according to the invention, component (A) is compound number X.06[3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenoxam, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0119] In another preferred composition according to the invention, component (A) is compound number X.07[N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluorobenzoate, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxastrobin Fluopyram, Fluoxazamide, Fluopyram, Captan, Emicrod, Indexpyram, Succinimidazole, Isofenoxanol, Isoxazolidinamide, Isopropoxyfenozide, Isothiazimid, Dipyridamole, Chlorfluazol, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluoxazolidinone, Fluopyram, Phosphite (phosphonate), Tetracycline, Prothioconazole, Fluopyram Hydroxylamine, Azoxystrobin, Quinoline, Fluopyram, Thiophanate, Corromycin Streptomyces, Tebuconazole, Flucypermethrin, Thiamethoxam, Trifluoromethoxycarb, Mefenoxam, Benzoylamidol, N-[(1R)-1-Benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl] Quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0120] In another preferred composition according to the invention, component (A) is compound number X.08[N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam, Fluoxadiazon, fluopyram, fluoxadiazonamide, fluoxadiazonamide, captan, emamectin, indapoxetine, styrazinazole, isofennoquine, isoxadiazonamide, isopyram, isothiazonamide, dimethomorph, chlorfluazon, metalaxyl, metalaxyl-M (metalaxyl), methyltetraproline, fluoxadiazon, fluoxadiazon aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadiazonyl hydroxylamine, pyraclostrobin, quinoline, fluoxadiazonamide, thiophanate-methyl, streptomycin, tebuconazole, flufenoxuronamide, thiamethoxam, triflumethoprim, benzoyl benzoate, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl The following are listed: [1S]-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0121] In another preferred composition according to the invention, component (A) is compound number X.09[N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0122] In another preferred composition according to the invention, component (A) is compound number X.10[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam Azoxystrobin, fluoxastrobin, fluopyram, fluoxastrobin, fluoxastrobin, captan, emamectin, indapoxetine, styrazin, isofennoquine, isoxaflutole, isopyram, isothiazin, dimethomorph, chlorfluazin, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxastrobin, fluoxastrobin aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxastrobin hydroxylamine, azoxystrobin, quinoline, fluoxastrobin, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, styrazin, benzoyl methoxycarb, tebuconazole, fluoxastrobin, thiamethoxam, triflumethoprim, benzoyl methoxycarb, benzoyl methoxycarb, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-methyl Amide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl The following are listed: [-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0123] In another preferred composition according to the invention, component (A) is compound number X.11[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0124] In another preferred composition according to the invention, component (A) is compound number X.12[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0125] In another preferred composition according to the invention, component (A) is compound number X.13[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzene-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0126] In another preferred composition according to the invention, component (A) is compound number X.14[N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxy-phenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofenil, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam Azoxystrobin, fluoxastrobin, fluopyram, fluoxastrobin, fluoxastrobin, captan, emamectin, indapoxetine, styrazin, isofennoquine, isoxaflutole, isopyram, isothiazin, dimethomorph, chlorfluazin, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxastrobin, fluoxastrobin aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxastrobin hydroxylamine, azoxystrobin, quinoline, fluoxastrobin, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, styrazin, benzoyl methoxycarb, tebuconazole, fluoxastrobin, thiamethoxam, triflumethoprim, benzoyl methoxycarb, benzoyl methoxycarb, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-methyl Amide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl The following are listed: [-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0127] In another preferred composition according to the invention, component (A) is compound number X.15[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzene-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fludioxonil, fludioxonil, fluopyram, fluopyram, Fluopyram, fluoxazin, fluopyram, fluoxazinamide, fluoxazinamide, captan, emamectin, indexpyram, styrazinazole, isofennoquine, isoxazinamide, isopyram, isothiazinamide, isothiazinamide, diyrylamide, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxazinamide, fluoxazinamide, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, trifluralin, styrazinamide, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3- Formamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl The following are listed: [-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0128] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.16[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanamide. Azoxystrobin, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, Thiosylsilane, Streptomycin, Tebuconazole, Flufenoxuron, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0129] In another preferred composition according to the invention, component (A) is compound number X.17[N-(4-fluoro-3-methoxy-phenyl)-3-[6-(methoxycarbamoylamino)-3-pyridinyl]-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzene-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenoxam, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam Pyram, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emamectin, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-methyl Amide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl The following are listed: [-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0130] In another preferred composition according to the invention, component (A) is compound number X.18[N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram Amide, fluoxadixyl sulfonate, fluopyram, fluoxadixylamide, fluoxadixylamide, captan, emetolide, indapoxetine, styrazinazole, isofennoquine, isoxadixylamide, isopyram, isothiazinamide, diyrylamide, chlorfluazol, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxadixyl acetophenone, fluoxadixyl aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxadixyl hydroxylamine, azoxystrobin, quinoline, fluoxadixylamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl sulfadiazine, benzoyl sulfadiazine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxyl Amines, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl- [Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0131] In another preferred composition according to the invention, component (A) is compound number X.19[N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzene-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluazinam, fluazinam, fluazinam, fluoxastrobin Sulfonate, Fluopyram, Fluoxazamide, Fluopyram, Captan, Emicrod, Indexpyram, Succinimidazole, Isofenoxanol, Isoxazolidinamide, Isopropoxyfenozide, Isothiazimid, Dipyridamole, Chlorfluazol, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluoxazolidinone, Fluopyram, Phosphite (phosphonate), Tetracycline, Prothioconazole, Fluopyram-hydroxylamine, Azoxystrobin, Quinoline, Fluopyram, Thiophanate-methyl, Corromycin, Streptomyces, Tebuconazole, Flufenoxuron, Thiamethoxam, Triflumethoprim, Mefenoxam, Benzoylamidol, N-[(1R)-1-Benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N- [(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl] Quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0132] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.20[N-[5-[8-acetamido-6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanidin Cymoxanil, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiamethoxam, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Fluopyram, Fluoxazinamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazinamide, Isopropoxyfenopyram, Isothiazinamide, Diyrylamide, Chlorfluazin, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram , thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0133] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.21[{N}-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralin Amines, Cyazofamid, Trifluopyridine, Cymoxanil, Difenoconazole, Disodium Phosphonate, Thiazolamide, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluindoxonil, Fluopyramide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indoxonil, Succinazole, Isofenoxanol, Isoxazonamide, Isopropoxyfenopyr, Isothiazonil, Dipyridamole, Chlorfluazon, Metalaxyl, Metalaxyl-M (Metalaxyl), Methyltetraproline, Fluthiazopyrone, Fluoxazonaniline, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluoxazonylhydroxylamine, Azoxystrobin, Quinoline, Fluoxazonium Acetamiprid, thiophanate-methyl, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N- [(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0134] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.22[N-[5-[6-[(2-methoxy-4-pyridinyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2-]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid. Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxyram, Fluoxyramsulfonate, Fluopyram, Fluoxyram, Fluoxyram, Fluoxyram, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazolamide, Isopropoxyfenopyram, Isothiazinam, Dimethomorph, Chlorfluazol, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram-hydroxylamine, Azoxystrobin, Quinoline, Fluopyram Thiosylsilane, Streptomycin, Tebuconazole, Flufenoxuron, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0135] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.23[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanidin Cymoxanil, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiamethoxam, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Fluopyram, Fluoxazinamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazinamide, Isopropoxyfenopyram, Isothiazinamide, Diyrylamide, Chlorfluazin, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram , thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0136] In a more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.01[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyanamide The compound contains cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0137] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.02[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, pyraclostrobin, etc. The compound contains cymoxanil, cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0138] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.03[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin The following compounds are included: chlorothalonil, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyraclostrobin, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0139] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.04[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, etc. The compound contains, among other compounds, including, cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, captan, dimethomorph, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzyl benzoate, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0140] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.05[N-[4-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidobenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, and cyanazin. The compound contains azole, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0141] In another preferred composition according to the invention, component (A) is compound number X.06 [3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyanamide. The compound contains cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0142] In another preferred composition according to the invention, component (A) is compound number X.07[N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidobenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trifluralin The ingredients include pyridinium chloride, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0143] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.08[N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxam, pyraclostrobin, chlorothalonil, and cyazofamid. The following compounds are included: trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0144] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.09[N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyanamide The compound contains cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0145] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.10[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, etc. Cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0146] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.11[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, etc. Cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0147] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.12[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyanamide. The compound contains cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0148] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.13[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyanamide. The compound contains cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0149] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.14[N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxy-phenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, etc. Cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0150] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.15[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil The following compounds are present: cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0151] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.16[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, and thiamethoxam. The compound contains cymoxanil, cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0152] In another preferred composition according to the invention, component (A) is compound number X.17 [N-(4-fluoro-3-methoxy-phenyl)-3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil. The following compounds are present: cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0153] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.18[N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, etc. Cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0154] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.19 [N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramacin-phenyl-S-methyl, azoxystrobin, indoxam, pyraclostrobin, chlorothalonil, cyazofamid, etc. The following compounds are present: trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, sulfadiazine, captan, dimethomorph, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0155] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.20[N-[5-[8-acetamido-6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, and thiamethoxam. The compound contains cymoxanil, cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0156] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.21[{N}-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxazole, pyrimethanil, etc. The mixture contains esters, chlorothalonil, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzoate, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0157] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.22[N-[5-[6-[(2-methoxy-4-pyridinyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, etc. The compound contains, among other compounds, including, cymoxanil, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, captan, dimethomorph, chlorfluazol, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzyl benzoate, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0158] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.23[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, and thiamethoxam. The compound contains cymoxanil, cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, diyrylamide, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamide, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0159] In a more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.01[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide, trifluralinamide, trifluralinamide Pyridine amine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridine amide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, sulfur silicon Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0160] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.02[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanidin Cymoxanil, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiamethoxam, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Fluopyram, Fluoxazinamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazinamide, Isopropoxyfenopyram, Isothiazinamide, Diyrylamide, Chlorfluazin, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram , thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0161] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.03[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralin Amines, Cyazofamid, Trifluopyridine, Cymoxanil, Difenoconazole, Disodium Phosphonate, Thiazolamide, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluindoxonil, Fluopyramide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indoxonil, Succinazole, Isofenoxanol, Isoxazonamide, Isopropoxyfenopyr, Isothiazonil, Dipyridamole, Chlorfluazon, Metalaxyl, Metalaxyl-M (Metalaxyl), Methyltetraproline, Fluthiazopyrone, Fluoxazonaniline, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluoxazonylhydroxylamine, Azoxystrobin, Quinoline, Fluoxazonium Acetamiprid, thiophanate-methyl, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N- [(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0162] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.04[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanamide. Azoxystrobin, trifluralinamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinamide, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, Thiosylsilane, Streptomycin, Tebuconazole, Flufenoxuron, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0163] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.05[N-[4-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide Amines, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiamethoxam, Benzopyrimidazole, Pyridabenamide, Fluazinam, Fludioxonil, Fluinbazinamide, Fluopyram, Fluopyram, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazinamide, Isopropoxyfenozide, Isothiazinam, Dipyridamole, Chlorfluazol, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram, Thiophanate-methyl , streptomycin, tebuconazole, flufenoxuron, thiabendazole, thiamethoxam, triflumethoprim, methamidophos, benzyladenine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 [R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0164] In another, even more preferred composition according to the invention, component (A) is compound number X.06 [3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide ... Pyridine amine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridine amide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, sulfur silicon Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0165] In another, even more preferred composition according to the invention, component (A) is compound number X.07[N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzene-S-methyl, azoxystrobin, indoxofensulfonamide, pyraclostrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluralinamide, cyazofamid, trifluralinamide, cymoxanil. Difenoconazole, disodium phosphonate, thiamethoxam, benzimidazole, pyridabenamide, fluazinam, fludioxonil, fluinbazinamide, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxanol, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazin, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, thiophanate-methyl, crown mold Streptomyces, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxide, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R) -1-Benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0166] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.08[N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide Cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fludioxonil, fluinbazinamide, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazin, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide, azoxystrobin, quinoline, fluoxazinamide, thiophanate-methyl , streptomycin, tebuconazole, flufenoxuron, thiabendazole, thiamethoxam, triflumethoprim, methamidophos, benzyladenine, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 [R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0167] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.09[N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide Pyridine amine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridine amide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, sulfur silicon Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0168] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.10[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxime, Isoxazonamide, Isopropoxyfenopyram, Isothiazin, Dimethomorph, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram-hydroxylamine, Azoxystrobin, Quinoline, Fluopyram, Thiophanate Siloamil, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0169] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.11[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide ... Flupyridamole, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyridamole, Flupyridamole, Fludioxonil, Fluinbazin, Flupyridamole, Flupyridamole, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyridamole, Succinazole, Isofenoxanol, Isoxazonamide, Isopropoxyfenozide, Isothiazolamide, Dipyridamole, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluoxazonamide, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluoxazonamide Hydroxylamine, Azoxystrobin, Quinoline, Fluoxazonamide, Sulfosyl Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0170] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.12[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide ... Pyridine amine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridine amide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, sulfur silicon Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0171] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.13[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide ... Pyridine amine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridine amide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, sulfur silicon Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0172] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.14 [N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxy-phenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxime, Isoxazonamide, Isopropoxyfenopyram, Isothiazin, Dimethomorph, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram-hydroxylamine, Azoxystrobin, Quinoline, Fluopyram, Thiophanate Siloamil, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0173] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.15[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid. Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxyram, Fluoxyramsulfonate, Fluopyram, Fluoxyram, Fluoxyram, Fluoxyram, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazolamide, Isopropoxyfenopyram, Isothiazinam, Dimethomorph, Chlorfluazol, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram-hydroxylamine, Azoxystrobin, Quinoline, Fluopyram Thiosylsilane, Streptomycin, Tebuconazole, Flufenoxuron, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0174] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.16[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanidin Cymoxanil, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiamethoxam, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Fluopyram, Fluoxazinamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazinamide, Isopropoxyfenopyram, Isothiazinamide, Diyrylamide, Chlorfluazin, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram , thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0175] In another, even more preferred composition according to the invention, component (A) is compound number X.17 [N-(4-fluoro-3-methoxy-phenyl)-3-[6-(methoxycarbamoylamino)-3-pyridinyl]-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, and cymoxanil. Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxime, Isoxazonamide, Isopropoxyfenopyram, Isothiazin, Dimethomorph, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram-hydroxylamine, Azoxystrobin, Quinoline, Fluopyram, Thiophanate Siloamil, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0176] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.18[N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide ... Flupyridamole, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidine, Pyridamole, Flupyridamole, Fludioxonil, Fluinbazin, Flupyridamole, Flupyridamole, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyridamole, Succinazole, Isofenoxanol, Isoxazonamide, Isopropoxyfenozide, Isothiazolamide, Dipyridamole, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluoxazonamide, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluoxazonamide Hydroxylamine, Azoxystrobin, Quinoline, Fluoxazonamide, Sulfosyl Azoxystrobin, Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0177] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.19 [N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyazofamid, trifluralinamide, and cymoxanil. Urea cyanide, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazin, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphonates, tetrazolium pyridaben, prothioconazole, fluoxazinamide, azoxystrobin, quinoline, fluoxazinamide, thiophanate-methyl, crown Streptomycin, Tebuconazole, Flufenoxuron, Thiabendazole, Thiamethoxam, Triflumethoprim, Mefenoxuron, Benzoylamidone, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R) [(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0178] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.20[N-[5-[8-acetamido-6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, Cyazofamid, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazonamide, Isopropoxyfenopyram, Isothiazin, Diyrylamide, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram Amine, thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N- [(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0179] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.21[{N}-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluoromethyl Pyridine amine, cyazofamid, triflupyridine amine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridine amide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, emetolide, indapoxetine, styrazinazole, isofenoxacin, isoxazinamide, isopyram, isothiazinamide, dimethomorph, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluthiamethoxam, fluoxazinamide, phosphite (phosphonate ester), tetrazolium pyridaben, prothioconazole, fluoxazinamide, pyraclostrobin, quinoline, fluoxazinamide Cyclosulfonamide, thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N -[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0180] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.22[N-[5-[6-[(2-methoxy-4-pyridyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2-]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, cyanidin Cymoxanil, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiamethoxam, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazinamide, Fluoxazinamide, Fluoxazinamide, Fluopyram, Fluoxazinamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazinamide, Isopropoxyfenopyram, Isothiazinamide, Diyrylamide, Chlorfluazin, Metalaxyl, Metalaxyl-M (Metalaxyl-M), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram , thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[ (1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0181] In another, even more preferred composition according to the invention, component (A) is methyl carbamate of compound number X.23[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: acetamiprid, aramidoylbenzyl-S-methyl, azoxystrobin, indoxofensulfonamide, azoxystrobin, Bacillus amyloliquefaciens, benzo[2]flufenican, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromoxynil, trifluralinamide, Cyazofamid, Trifluopyridine, Cymoxanil, Difenoconazole, Sodium Phosphonate, Thiazolamide, Benzopyrimidazole, Pyroxyfenamide, Fluazinam, Fludioxonil, Fluinbazin, Fluopyram, Fluopyram, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Fluoxazonamide, Captan, Emicrod, Indexpyram, Succinazole, Isofenoxanol, Isoxazonamide, Isopropoxyfenopyram, Isothiazin, Diyrylamide, Chlorfluazon, Metalaxyl, Metalaxyl-M (Methamphetamine), Methyltetraproline, Fluthiazopyrone, Fluopyram, Phosphite (phosphonate ester), Tetracycline, Prothioconazole, Fluopyram, Azoxystrobin, Quinoline, Fluopyram Amine, thiodicarb, streptomycin, tebuconazole, flufenoxuron, thiamethoxam, trifluoperoxynil, methamidophos, benomyl, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N- [(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,[3-Dimethyl-Butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0182] In a most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.01[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0183] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.02[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trifluralin The following compounds are included: pyridinium chloride, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0184] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.03[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, etc. The following compounds are present in a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0185] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.04[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxam, pyraclostrobin, chlorothalonil, cyazofamid, trifluralin The mixture contains pyridamole, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0186] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.05[N-[4-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine, and cymoxanil. Urea cyanide, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzoate and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0187] In another most preferred composition according to the invention, component (A) is compound number X.06 [3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0188] In another preferred composition according to the invention, component (A) is compound number X.07[N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxam, pyraclostrobin, chlorothalonil, cyazofamid, trifluoropyridamole, cymoxanil ... The mixture contains difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0189] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.08[N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine, and cymoxanil. Urea cyanide, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzoate and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0190] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.09[N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0191] In another preferred composition according to the invention, component (A) is compound number X.10[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine The mixture contains amines, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzoate, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0192] In another preferred composition according to the invention, component (A) is compound number X.11[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0193] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.12[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0194] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.13[N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0195] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.14 [N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxy-phenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine The mixture contains amines, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzoate, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0196] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.15[N-[5-[6-[(4-chloro-3-methoxy-phenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxam, pyraclostrobin, chlorothalonil, cyazofamid, trifluralin The mixture contains pyridamole, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0197] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.16[N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trifluralin The following compounds are included: pyridinium chloride, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0198] In another most preferred composition according to the invention, component (A) is compound number X.17 [N-(4-fluoro-3-methoxy-phenyl)-3-[6-(methoxycarbamoylamino)-3-pyridinyl]-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramacin-phenyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine The mixture contains amines, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzoate, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0199] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.18[N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-benzene-S-methyl, azoxystrobin, indoxam, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine. The following are listed: cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzyl benzo ...

[0200] In another preferred composition according to the invention, component (A) is methyl carbamate of compound number X.19 [N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramidoylbenzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trifluoropyridinium, cymoxanil. The mixture contains, among other ingredients, including difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluoxastrobin hydroxylamine, fluoxastrobin, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0201] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.20[N-[5-[8-acetamido-6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trimethoprim. Flupyridamole, cymoxanil, difenoconazole, disodium phosphonate, pyridamole, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0202] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.21[{N}-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, and cyazofamid. The following compounds are included: trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0203] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.22[N-[5-[6-[(2-methoxy-4-pyridinyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trifluralin The following compounds are included: pyridinium chloride, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fluazinam, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0204] In another most preferred composition according to the invention, component (A) is methyl carbamate of compound number X.23[N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate] or a salt or N-oxide thereof, and component (B) is a compound selected from the group consisting of: aramid-type benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, chlorothalonil, cyazofamid, trimethoprim. Flupyridamole, cymoxanil, difenoconazole, disodium phosphonate, pyridamole, fluazinam, fluazinam, fluopyram, fluoxastrobin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam hydroxylamine, fluazinam, streptomycin, benzylamidoquin, and compound Z (feneptamidoquin), wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0205] In any preferred composition according to the invention, the composition may comprise an additional active ingredient component (C), which differs from component (B) and is selected from the group consisting of: acetamiprid, aramid-benzene-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, Bacillus amyloliquefaciens, benzo[a]fluopyram, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, trifluopyridine, cyazofamid, trifluopyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fluazinam, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide Amide, captan, Emikpuld, indapoxetine, styrazinazole, isofennoquine, isoxaflutole, isopyram, isothiazinazole, dicytylosinazole, chlorfluazinazole, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxetine, fluoxetine aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxetine hydroxylamine, azoxystrobin, quinoline, fluoxetine, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, benzoyl benzoate, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[( [1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)] [Methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide.

[0206] The compositions according to the invention can be used in the agricultural sector and related applications to control plant pests or on non-living materials to control putrefactive microorganisms or potentially harmful organisms. The compositions can inhibit or destroy pests appearing on various useful plant crops or plant parts (fruits, flowers, leaves, stems, tubers, roots), while also protecting, for example, later-growing plant parts from plant pathogenic microorganisms.

[0207] The composition may also be used as a fungicide. As used herein, the term "fungicide" means a compound that controls, alters, or prevents fungal growth. The term "fungicide effective amount" means the amount of such a compound or combination of such compounds that can affect fungal growth. Controlling or altering effects include all deviations from natural development, such as killing, inhibiting, etc., and prevention includes the formation of barriers or other defenses within or on the plant to prevent fungal infection. The composition according to the invention may contain a fungicide effective amount of component A and / or component B.

[0208] As used herein, the term "site" means the place in which or on which a plant grows, or the place where the seeds of a cultivated plant are sown, or the place where the seeds will be placed in the soil. It includes soil, seeds, and seedlings, along with the established vegetation.

[0209] The term "plant" refers to all the tangible parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, culms, leaves, and fruits.

[0210] The compositions according to the invention can also be used as seed dressings for treating plant propagation material, protecting it from fungal infection and from plant pathogenic fungi present in the soil. The propagation material can be treated with the compositions according to the invention before planting: for example, seed dressing can be used before sowing. The compositions according to the invention can also be applied to grains (coating) by soaking seeds in a liquid formulation or by coating them with a solid formulation. The compositions can also be applied to the planting site when planting the propagation material, for example, by applying them to the furrows of the seeds during sowing. The invention also relates to such methods of treating plant propagation material, and to plant propagation material treated in this way.

[0211] The term "plant propagation material" should be understood to refer to the reproductive parts of a plant, such as seeds, which can be used for plant propagation, as well as nutrient materials, such as cuttings or tubers (e.g., potatoes). References may include, for example, seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes, and parts of the plant. References may also include germinating plants and young plants that will be transplanted after germination or emergence. These young plants may be protected before transplanting by complete or partial treatment with maceration. Preferably, "plant propagation material" should be understood to refer to seeds.

[0212] The pesticides mentioned in this article that use their common names are known, for example, from "The Pesticide Manual", 19th edition, British Crop Protection Council 2021.

[0213] Furthermore, the compositions according to the invention can be used to control fungi in relevant fields, such as the protection of industrial materials (including wood and wood-related industrial products), food storage, and hygiene management.

[0214] In addition, the present invention can be used to protect non-living materials (such as wood, wall panels and coatings) from fungal invasion.

[0215] The compositions according to the invention are effective against harmful microorganisms (such as microorganisms) that cause plant pathogenic diseases, especially against plant pathogenic fungi and bacteria.

[0216] The compositions of the present invention can be used to control plant diseases caused by a broad spectrum of fungal plant pathogens, including Basidiomycetes, Ascomycetes, Oomycetes and / or Deuteromycetes, Blasocladiomycete, Chrytidiomycete, Glomeromycete and / or Mucoromycete, and more preferably Oomycetes.

[0217] The compositions of the present invention effectively control a broad spectrum of plant diseases, such as leaf pathogens in ornamental plants, turf, vegetables, fields, cereals, and fruit crops.

[0218] These pathogens may include:

[0219] Oomycetes include Phytophthora diseases, such as those caused by *Phytophthora capsici*, *Phytophthora causalosa*, *Phytophthora soybeani*, *Phytophthora fragariae*, *Phytophthora nicotianae*, *Phytophthora cinnamomi*, *Phytophthora citricola*, *Phytophthora citrophthora*, and *Phytophthora erythroseptica*; Pythium diseases, such as those caused by *Pythium cucurbitae*, *Pythium arrhenomanes*, *Pythium gracilis*, *Pythium irregulare*, *Pythium sylvaticum*, and *Pythium tertruncatum*; and Downycetes such as *Peronospora destructor*, *Peronospora cabbageii*, and *Plasmopara*. Diseases caused by *Viticola*, *Downy mildew* of sunflower, *Downy mildew* of cucumber, *Albugo candida*, downy mildew of rice, and downy mildew of lettuce; as well as others, such as those caused by *Hymenopterus sclerospora*, *Labyrinthula zosterae*, *Peronosclerospora sorghi*, and *Sclerospora graminicola*.

[0220] Ascomycetes, including diseases such as spot, blight, wilt, or downy mildew and / or rot, such as those caused by the following: *Stemphylium solani* (garlic white spot fungus), *Stagonosporatainanensis* (Tainan daffodil), *Setosphaeria turcica* (corn large leaf spot fungus), *Pyrenochaeta lycoperisici* (tomato bark fungus), *Stemphylium solani* (leaf rot fungus), *Phoma destructiva* (stem rot fungus), *Phaeosphaeria herpotrichoides* (wheat leaf dark spot fungus), *Phaeocryptocus gaeumannii* (brown cryptococcus), *Ophiosphaerella graminicola* (grass rot fungus), *Ophiobolus graminis* (wheat take-all fungus), *Leptosphaeria maculans* (cruciferous small spore fungus), *Hendersonia creberrima* (soft rot fungus), *Helminthosporium* (leaf blight fungus). The fungi causing the following diseases are listed: triticirepentis, corn leaf blight (Setosphaeria turcica), soybean umbelliferous spores (Drechslera glycines), watermelon vine blight (Didymella bryoniae), olive pea bud blight (Cycloconium oleagineum), corynespora cassiicola, spore-forming fungus, dragon fruit black spot (Bipolaris cactivora), apple black spot fungus, round spore fungus, oat spore fungus (Pyrenophora triticirepentis), alternating algal spores, brassicicola, solanum algal spores, and tomato algal spores.Capnodiales include species such as *Septoriaglycines*, *Cercospora arachidicola*, *Cercosporella capsellae*, *Cercosporella herpotrichoides*, *Cladosporium carpophilum*, *Cladosporium effusum*, *Passalora fulva*, *Cladosporium oxysporum*, *Dothistromaseptosporum*, *Isariopsis clavispora*, *Mycosphaerella graminicola*, and *Mycovellosiella*. *Phaeoisariopsis bataticola*, *Pseudocercospora vitis*, *Pseudocercospora ... Clavicipiti-juglandacearum), Tubakia dryina, Dicarpella spp., Valsa ceratosperma (the causal agent of apple tree rot);Others include Actinothyrium graminis, pea pod spores, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidus, *Pachyphytum spp.*, *Blumeriella jaapii*, species of *Candida*, *Capnodium ramosum*, species of *Cephaloascus*, *Cephalosporium gramineum*, *Ceratocystis paradoxa*, species of *Chaetoceros*, *Hymenoscyphus pseudoalbidus*, species of *Cylindrosporium*, *Cylindrosporium padi*, *Diplocarpon malae*, *Drepanopeziza campestris*, and *Elsinoe*. (ampelina), black spores, species of Epidermophyton, grape top blight, white ground mold, Gibellina cerealis, Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perennans;Endophytic fungi of dead wheat (Gloeotinia temulenta), dermal septum (Griphospaeria corticola), Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola, Microdochium nivale, Monilinia fructicola (Monilinia fructicola), Monographella albescens (Monosporascus cannonballus), species of Naemacyclus spp., Ophiostoma novo-ulmi (Ophiostoma novo-ulmi), Paracoccidioides brasiliensis, Penicillium expansum * *Expansum*, *Pestalotia rhododendri*, *Petriellidium* spp., *Pezicula* spp., *Phialophora gregata*, *Phyllachorapomigena*, *Phymatotrichum omnivora*, *Physalospora abdita*, *Plectosporium tabacinum*, *Polyscytalumpustulans*, *Pseudopezi*; z a medicaginis), Pyrenopezi z *Rhamnus abrassicae*, *Ramulispora sorghi*, *Rhabdoclinepseudotsugae*, *Rhynchosporium secalis*, *Sacrocladium oryzae*, *Scedosporium spp.*, *Schizophyllum commune* zo*Sclerotinia pomi*, *Sclerotinia sclerotiorum*, *Sclerotinia minor*; species of the genus *Sclerotium*, *Typhula ishikariensis*, *Seimatosporium mariae*, *Lepteutypa cupressi*, *Septocyta ruborum*, *Sphaceloma perseae*, *Sporonemaphacidioides*, *Stigmina palmivora*, *Tapesiayallundae*, *Taphrina bullata*, *Thielviopsis basicola*, *Trichoseptoria* fructigena), fly dung fungus (Zygophialajamaicensis); powdery mildew, such as those caused by powdery mildew fungi such as wheat powdery mildew, knotweed powdery mildew, grape powdery mildew, cucumber powdery mildew (Sphaerotheca fuligena), white powdery mildew, spotted powdery mildew (Podospaera macularis), disporous powdery mildew (Golovinomyces cichoracearum), Tartary powdery mildew (Leveillula taurica), diffuse powdery mildew, cotton powdery mildew (Oidiopsis gossypii), hazelnut needle-shell (Phyllactinia guttata), and peanut powdery mildew (Oidium arachidis); molds, such as those caused by staphylococcal fungi such as Dothiorella aromatica, Diplodia seriata, Guignardia bidwellii, and Botrytis. The fungi causing these diseases include: *Botryotinia allii*, *Botryotinia fabae*, *Fusicoccum amygdali*, *Lasiodiplodia theobromae*, *Macrophoma theicola*, *Coccidioidomyces cerevisiae*, and *Phyllosticta cucurbitacearum*.Anthracnose, such as those caused by Glommerelales (e.g., Colletotrichum lagenarium), cotton anthracnose fungus, periglomeratus, and gramineous anthracnose fungus; and wilt or blight, such as those caused by Hypocreales (e.g., Atoporphyra yezoensis, Ergotia purpurea, Fusarium graminearum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusarium glomeratum, Fusarium oxysporum f.sp. cubense, Gerlachia nivale, Fusarium fujikuroi, Fusarium graminearum, Fusarium graminearum, Gynostemma pentaphyllum, L. verrucosum, Nectria ramulariae, Trichoderma viride, Polysporium rosenbergii, and Verticillium theobromae).

[0221] Basidiomycetes include diseases such as smut caused by smut fungi such as *Ustilaginoidea virens*, *Ustilago nuda*, *Ustilago tritici*, and *Ustilago zeae*, and rust diseases caused by stalk rust fungi such as *Cerotelium fici*, *Chrysomyxa arctostaphyli*, *Coleosporium ipomoeae*, *Hemileia vastatrix*, *Puccinia arachidis*, *Puccinia cacabata*, *Puccinia graminis*, *Puccinia recondita*, *Puccinia sorghi*, *Puccinia hordei*, and *Puccinia striiformis*. f.sp.Hordei), Puccinia striiformisf.sp.Those caused by *Secalis*, *Pucciniastrum coryli*; or rust fungi such as *Cronartium ribicola*, *Gymnosporangium juniperi-viginianae*, *Melampsora medusae*, *Phakopsora pachyrhizi*, *Phragmidium mucronatum*, *Physopella ampelosidis*, *Tranzschelia discolor*, and *Uromyces viciae-fabae*; and other rots and diseases, such as those caused by species of *Cryptococcus*, *Exobasidium vexans*, *Marasmiellus inoderma*, *Sphagnum*, and *Sphacelotheca*. Those caused by *Sclerotium reiliana*, *Typhula ishikariensis*, *Urocystis agropyri*, *Itersonilia perplexans*, *Corticium invisum*, *Laetisaria fuciformis*, *Waitea circinata*, *Rhizoctonia solani*, *Thanetephorus cucurmeris*, *Entyloma dahliae*, *Entylomella microspora*, *Neovossia moliniae*, and *Tilletia caries*.

[0222] Cladosporidioides, such as Physoderma maydis;

[0223] Mucormycetes, such as *Choanephora cucurbitarum*; species of the genus *Mucor*; *Rhizopus* spp.

[0224] Together with diseases caused by other species and genera closely related to those listed above.

[0225] In addition to their antifungal activity, the compositions according to the invention may also have activity against bacteria such as *Pyrus pyrifolia*, *Erwinia caratovora*, *Xanthomonas laurentii*, *Pseudomonas syringae*, *Strptomyces scabies*, and other related species, along with certain protozoa.

[0226] Within the scope of this invention, the target crops and / or useful plants to be protected typically include perennial and annual crops, such as berry plants, such as blackberries, blueberries, cranberries, raspberries, and strawberries; cereals, such as barley, corn, millet, oats, rice, rye, sorghum, triticale, and wheat; fiber plants, such as cotton, flax, hemp, jute, and sisal; field crops, such as sugar beets and forage beets, coffee beans, hops, mustard, canola, poppies, sugarcane, sunflowers, tea, and tobacco; fruit trees, such as apples, apricots, avocados, bananas, cherries, citrus fruits, nectarines, peaches, pears, and plums; and grasses, such as Bermuda grass, bluegrass, benjamin grass, centipede grass, sedge, and black clover. Wheatgrass, St. Augustine grass, and zoysia grass; herbs such as basil, borage, chives, coriander, lavender, angelica, mint, oregano, parsley, rosemary, sage, and thyme; legumes such as kidney beans, lentils, peas, and soybeans; nuts such as almonds, cashews, peanuts, hazelnuts, peanuts, pecans, pistachios, and walnuts; palm trees such as oil palms; ornamental plants such as flowers, shrubs, and trees; other trees such as cacao trees, coconut palms, olive trees, and rubber trees; vegetables such as asparagus, eggplant, broccoli, cabbage, carrots, cucumbers, garlic, lettuce, zucchini, melons, okra, onions, peppers, potatoes, squash, rhubarb, spinach, and tomatoes; and grapevines such as grapes.

[0227] The useful plants and / or target crops according to the invention include conventional varieties with genetic enhancement or genetic engineering treatments, such as insect-resistant varieties (e.g., Bt. and VIP varieties) along with disease-resistant and herbicide-tolerant varieties (e.g., glyphosate-resistant and glufosinate-resistant maize varieties, under trademarks). and Commercially available) and nematode-tolerant varieties. By way of example, suitable genetically enhanced or genetically engineered crop varieties include Stoneville 5599BR cotton and Stoneville 4892BR cotton.

[0228] The terms "useful plants" and / or "target crops" should be understood to also include useful plants that have developed tolerance to herbicides (like bromuconazole) or herbicide classes (e.g., HPPD inhibitors, ALS inhibitors such as flusulfuron, flusulfuron-methyl, and triflusulfuron-methyl, EPSPS (5-enol-pyruvyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthase) inhibitors, or PPO (protoporphyrinogen-oxidase) inhibitors) through conventional breeding or genetic engineering methods. Examples of crops that have been induced to tolerate imidazolinones (e.g., methoxyfenozide) through conventional breeding methods (mutation) are... Summer rapeseed (Carnora). Examples of crops that have been genetically engineered to be resistant to herbicides or herbicides include glyphosate-resistant and glufosinate-resistant maize varieties, marketed under the brand name Carnora. Herculex and Available for commercial purchase.

[0229] The terms “useful plant” and / or “target crop” should be understood to include those that are naturally or have been conditioned to be resistant to harmful insects. This includes plants transformed using recombinant DNA technology to, for example, synthesize one or more selectively acting toxins, as known from, for example, toxin-producing bacteria. Examples of toxins that can be expressed include δ-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins from nematode-parasitic bacteria, and toxins produced by scorpions, arachnids, wasps, and fungi. An example of a crop modified to express Bacillus thuringiensis toxins is Btmaize. (Syngenta Seeds). Examples include crops that encode insecticidal resistance and thereby express more than one gene for more than one toxin. (Syngenta Seeds). Crops or their seed material can also be resistant to multiple types of pests (so-called superimposed transgenic events when produced through genetic modification). For example, plants can express insecticidal proteins while being resistant to herbicides, such as Herculex. (Dow AgroSciences, Pioneer Hi-Bred International)

[0230] The terms “useful plant” and / or “target crop” should be understood to also include useful plants that have been transformed using recombinant DNA technology to synthesize selectively active resistance substances, such as so-called “pathogenic mechanism-associated proteins” (PRPs, see, for example, EP-A-0 392 225). Examples of such resistance substances and transgenic plants capable of synthesizing such resistance substances are known, for example, from EP-A-0 392 225, WO 95 / 33818, and EP-A-0 353 191. Methods for producing such transgenic plants are generally known to those skilled in the art and are described, for example, in the disclosures mentioned above.

[0231] Toxins that can be expressed by transgenic plants include, for example, insecticidal proteins from *Bacillus cereus* or *Bacillus japonicus*; or insecticidal proteins from *Bacillus thuringiensis*, such as δ-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C, or vegetative insecticidal proteins (Vip), such as Vip1, Vip2, Vip3, or Vip3A; or insecticidal proteins from nematode-parasitic bacteria, such as species of *Photorhabdus* spp. or species of *Xenorhabdus* spp., such as *Photorhabdus luminescens* and *Xenorhabdus* spp. nematophilus; animal-derived toxins such as scorpion venom, spider venom, bee venom, and other insect-specific neurotoxins; fungal toxins such as streptotoxins; plant lectins such as pea lectin, barley lectin, or snowdrop lectin; agglutinin; protease inhibitors such as trypsin inhibitors, serine protease inhibitors, potato glycoprotein, cysteine ​​protease inhibitors, and papain inhibitors; ribosome-inactivating proteins (RIPs) such as ricin, corn-RIP, abrin, loofah seed toxin, saponin toxin, or cassia root toxin; steroid metabolic enzymes such as 3-hydroxysteroid oxidase, decidual steroid-UDP-glycosyltransferase, cholesterol oxidase, decidualin inhibitors, HMG-COA-reductase, ion channel blockers such as sodium or calcium channel blockers, juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase, and glucanase.

[0232] Furthermore, in the context of this invention, δ-endotoxins (e.g., Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C) or vegetative insecticidal proteins (Vip) (e.g., Vip1, Vip2, Vip3, or Vip3A) should be understood to obviously also include mixed toxins, truncated toxins, and modified toxins. Mixed toxins are generated through novel recombination of different combinations of the different domains of those proteins (see, for example, WO 02 / 15701). Truncated toxins, such as truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are substituted. In such amino acid substitutions, it is preferable to insert a non-naturally occurring protease recognition sequence into the toxin, for example, as in the case of Cry3A055, the cathepsin-G-recognition sequence is inserted into the Cry3A toxin (see WO 03 / 018810).

[0233] Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, for example, in EP-A-0 374753, WO 93 / 07278, WO 95 / 34656, EP-A-0 427 529, EP-A-451 878 and WO 03 / 052073.

[0234] Methods for preparing such transgenic plants are generally known to those skilled in the art and are described in, for example, the disclosures mentioned above. CryI type deoxyribonucleic acid and its preparation are known, for example, from WO 95 / 34656, EP-A-0 367474, EP-A-0 401 979 and WO 90 / 13651.

[0235] The toxins contained in genetically modified plants make them resistant to harmful insects. These insects can exist in any insect taxonomy, but are particularly common in beetles (Coleoptera), dipterans (Diptera), and moths (Lepidoptera).

[0236] Transgenic plants containing one or more genes encoding resistance to insecticides and expressing one or more toxins are known, and some of these are commercially available. Examples of such plants are: (Corn variety expressing Cry1Ab toxin); YieldGard (A maize variety expressing the Cry3Bb1 toxin); YieldGard (A maize variety that expresses Cry1Ab and Cry3Bb1 toxins); (A maize variety that expresses the Cry9C toxin); Herculex (A maize variety that expresses the Cry1Fa2 toxin and the enzyme that acquires tolerance to the herbicide glufosinate-phosphinic acid N-acetyltransferase (PAT)); NuCOTN (Cotton variety expressing Cry1Ac toxin); Bollgard (Cotton variety expressing Cry1Ac toxin); Bollgard (Cotton variety expressing Cry1Ac and Cry2Ab toxins); (Cotton variety expressing Vip3A and Cry1Ab toxins); (Potato variety that expresses Cry3A toxin); GT Advantage (GA21 glyphosate resistance) CB Advantage (Bt11 corn borer (CB) traits) and

[0237] Other examples of such genetically modified crops are:

[0238] 1. Bt11 maize, from Syngenta Seeds SAS, Chemindel'Hobit 27, F-31 790 St. Sauveur, France, Registry No. C / FR / 96 / 05 / 10. A genetically modified maize variety that expresses a truncated Cry1Ab toxin to resist the European corn borer (corn borer and mealybug). Bt11 maize is also genetically modified to express the enzyme PAT to gain tolerance to the herbicide glufosinate.

[0239] 2. Bt176 maize, from Syngenta Seed Company, 27 Hobbit Road, F-31 790 Saint-Soville, France, Registry No. C / FR / 96 / 05 / 10. A genetically modified maize variety that expresses the Cry1Ab toxin transgenically, making it resistant to the European corn borer (corn borer and mealybug). Bt176 maize is also transgenic to express the enzyme PAT for tolerance to the herbicide glufosinate.

[0240] 3. MIR604 maize, from Syngenta Seed Company, 27 Hobbit Road, F-31 790 Saint-Soville, France, registration number C / FR / 96 / 05 / 10. A transgenic maize plant resistant to insects by expressing a modified Cry3A toxin. This toxin is modified by inserting a cathepsin-G-protease recognition sequence, Cry3A055. The preparation of this type of transgenic maize plant is described in WO 03 / 018810.

[0241] 4. MON 863 maize, from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / DE / 02 / 9. MON 863 expresses Cry3Bb1 toxin and is resistant to certain Coleoptera insects.

[0242] 5. IPC 531 cotton, from Monsanto Europe, 270-272 Tefallen Boulevard, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02.

[0243] 6.1507 Maize, from Pioneer Overseas Corporation, Avenue Tedesco, 7B-1160 Brussels, Belgium, Registry No. C / NL / 00 / 10. Genetically modified maize expressing the protein Cry1F to acquire resistance to certain lepidopteran insects and expressing the PAT protein to acquire tolerance to the herbicide glufosinate.

[0244] 7. NK603 × MON 810 maize, from Monsanto Europe, 270-272 Boulevard de Tverren, B-1150 Brussels, Belgium, Registry No. C / GB / 02 / M3 / 03. Composed of conventionally bred hybrid maize varieties by crossing the genetically modified cultivar NK603 with MON 810. The NK603 × MON 810 maize transgenic plot expresses the protein CP4 EPSPS obtained from the Agrobacterium strain CP4, which confers resistance to herbicides. It exhibits tolerance to glyphosate and also expresses Cry1Ab toxin derived from Bacillus thuringiensis Kurstak subspecies, which provides tolerance to certain lepidopteran insects, including the European corn borer.

[0245] The compounds having formula (I) used according to the present invention can be prepared as shown in schemes 1 to 19 below, wherein (unless otherwise stated) each variable is defined as defined in the present invention.

[0246] Compounds having formula (I) can be produced by combining compounds having formula (II) (where X is chlorine (Cl), bromine (Br), or iodine (I)) and compounds having formula (III) (where any R... 7 Each of the following is independently hydrogen, C1-C6 alkyl, or two of the R groups. 7The reaction can be prepared by Suzuki cross-coupling in the presence of a base such as Cs₂CO₃, K₂CO₃, or NaOtBu and a suitable palladium catalyst such as tetra(triphenylphosphine)palladium, palladium dichloride, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), palladium acetate, or bis(diphenylphosphine)palladium(II) chloride, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water. This transformation is depicted in Scheme 1.

[0247]

[0248] Compounds having formula (II) (where X is Cl, Br, or I) can be prepared by reacting a compound having formula (IV) (where X is Cl, Br, or I) with a compound having formula (V) and a coupling agent such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolyl)phosphinic acid chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylureon hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuric chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This transformation is depicted in Scheme 2.

[0249]

[0250] Compounds having formula (IV) (where X is Cl, Br, or I) are commercially available, or alternatively, compounds having formula (VI) (where X is Cl, Br, or I and R) can be prepared by using a base such as NaOH or LiOH. 8 It is prepared by saponification in a suitable solvent such as methanol, ethanol or water at a temperature between retention time (RT) and reflux. This transformation is described in Scheme 3.

[0251]

[0252] Alternatively, a compound having formula (II) (where X is Cl, Br, or I) can be produced by making a compound having formula (VI) (where X is Cl, Br, or I and R) 8The compounds of formula (V) and C1-C6 alkyl groups are directly prepared by reacting them in a suitable solvent such as tetrahydrofuran or toluene in the presence of (CH3)3Al or bis(trimethylaluminum)-1,4-diazabicyclo[2.2.2]octane adducts. These transformations have been described in the literature (see, for example: Weinreb, SM et al., Tetrahedron Letters, 1977, 48, 4171; Woodward, S. et al., Tetrahedron Letters, 2006, 47, 5767; Woodward S. et al., Organic Process Res. Dev., 2015, 19, 831). This transformation is depicted in scheme 4.

[0253]

[0254] Compounds having formula (VI) (where X is Cl, Br, or I and R) 8 (is C1-C6 alkyl) is commercially available, or alternatively can be derived from compounds having formula (VII) (wherein R is C1-C6 alkyl) 8 It is prepared by reacting a C1-C6 alkyl group with a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, or bromine in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, or acetonitrile. This transformation is depicted in Scheme 5.

[0255]

[0256] Compounds having formula (VII) (where R) 8 (C1-C6 alkyl) is commercially available, or alternatively can be obtained by reacting a compound having formula (VIII) (where X is Cl, Br, or I) with carbon monoxide and alcohol R. 8 OH (where R) 8 It is a C1-C6 alkyl group, reacted in the presence of a catalyst such as bis(diphenylphosphino)ferrocene]dichloropalladium(II) and optionally a base such as triethylamine to prepare it. This transformation is depicted in Scheme 6.

[0257]

[0258] Compounds having formula (VIII) are commercially available, or alternatively can be produced by using compounds having formula (IX) (where X is Cl, Br, or I) and compounds having formula (X) (where X is Cl, Br, or I) or their corresponding acetals having formula (XI) (where X is Cl, Br, or I, and any R...). 9 Each is independently a C1-C6 alkyl group, or two of them are R. 9The reaction can form C3-C8 cycloalkyl groups in solvents such as water, ethanol, acetone, or acetonitrile to prepare the product. In some cases, the outcome of the reaction can be improved by using a base such as sodium bicarbonate or potassium carbonate, or by using an acid such as p-toluenesulfonic acid or hydrogen bromide. Furthermore, this transformation can be utilized from compounds having the formula (XII) (where R...) 8 To prepare compounds having formula (VII) (where R is a C1-C6 alkyl group) 8 (These are C1-C6 alkyl groups), and the preparation of compounds having formula (XIII) from compounds having formula (XIV). These transformations are depicted in Scheme 7.

[0259]

[0260] Compounds having formula (IX) (where X is Cl, Br, or I), and compounds having formula (XII) (where R is Cl, Br, or I) 8 They are C1-C6 alkyl groups, and compounds having the formula (XIV) are prepared by known methods or are commercially available.

[0261] Alternatively, compounds having formula (I) can be prepared by reacting a compound having formula (XV) with a compound having formula (V) and a coupling agent such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphinic acid chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylureon hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuric chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This transformation is depicted in Scheme 8.

[0262]

[0263] Compounds having formula (XV) can be converted into compounds having formula (XVI) (where R) by using a base such as NaOH or LiOH. 8 It is prepared by saponification of (C1-C6 alkyl) in a suitable solvent such as methanol, ethanol or water at a temperature between room temperature and reflux. This transformation is described in Scheme 9.

[0264]

[0265] Compounds having formula (XVI) (where R) 8 (It is a C1-C6 alkyl) can be made by making a compound having formula (VI) (where X is Cl, Br or I and R is C1-C6 alkyl) 8 (are C1-C6 alkyl) and compounds having formula (III) (wherein any R) 7Each of the following is independently hydrogen, C1-C6 alkyl, or two of the R groups. 7 The compounds can be prepared by Suzuki cross-coupling in the presence of a base such as Cs₂CO₃, K₂CO₃, or NaOtBu and a suitable palladium catalyst such as tetra(triphenylphosphine)palladium, palladium dichloride, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), palladium acetate, or bis(diphenylphosphine)palladium(II) chloride, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water. Furthermore, this transformation can be used to prepare compounds of formula (XV) from compounds having formula (IV). These transformations are depicted in Scheme 10.

[0266]

[0267] Alternatively, compounds having formula (II) (where X is Cl, Br, or I) can be prepared by reacting a compound having formula (XVII) with a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, or bromine in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, or acetonitrile. This transformation is depicted in Scheme 11.

[0268]

[0269] Compounds having formula (XVII) can be prepared by reacting a compound having formula (XIII) with a compound having formula (V) and a coupling agent such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphonochloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylureon hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride or cyanuric chloride, and optionally a base such as triethylamine, ethyldiisopropylamine or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran or dichloromethane. This transformation is depicted in Scheme 12.

[0270]

[0271] Alternatively, compounds having formula (XVII) can be synthesized by reacting a compound having formula (VIII) (where X is Cl, Br, or I) with an amine having formula (V) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II) and optionally a base such as triethylamine or sodium carbonate. This transformation is depicted in Scheme 13.

[0272]

[0273] Alternatively, compounds of formula (II) can be prepared by reacting a compound of formula (XVIII) with a compound of formula (XIX) (where Y is Cl, Br, I, OSO2CF3, OSO2C6H4CH3, or OSO2CH3) in the presence of a base such as Cs2CO3, K2CO3, or NaOtBu. This transformation is depicted in Scheme 14.

[0274]

[0275] Compounds having formula (XVIII) (where X is Cl, Br, or I) can be prepared by reacting a compound having formula (IV) (where X is Cl, Br, or I) with a compound having formula (XX) and a coupling agent such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolyl)phosphinic acid chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylureon hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuric chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This transformation is depicted in Scheme 15.

[0276]

[0277] Alternatively, compounds having formula (I) can be synthesized by reacting a compound having formula (XXI) (where X is Cl, Br, or I) with an amine having formula (V) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II) and optionally a base such as triethylamine or sodium carbonate. This transformation is depicted in Scheme 16.

[0278]

[0279] A compound having formula (XXI) (where X is Cl, Br, or I) can be produced by a compound having formula (XXII) (where any X is Cl, Br, or I independently of each other), through contact with a compound having formula (III) (where any R... 7 Hydrogen and C are independent of each other. 1-6 Alkyl, or two of the Rs 7 Together they can form C 3-8Cycloalkyl groups are prepared by Suzuki cross-coupling in the presence of a base such as Cs₂CO₃, K₂CO₃, or NaOtBu and a suitable palladium catalyst such as tetra(triphenylphosphine)palladium, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride, or palladium acetate in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water. Compounds having formula (XXII) (where any X is independently Cl, Br, or I) can be prepared by halogenating compounds having formula (VII) (where X is Cl, Br, or I) in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, or acetonitrile using a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, or brominated compounds. These transformations are depicted in Scheme 17.

[0280]

[0281] Alternatively, compounds having formula (I) can be prepared by reacting a compound having formula (XXIII) with a compound having formula (XXIV) (where Y is OH) and a coupling agent such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphonochloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylureon hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride or cyanuric chloride, and optionally a base such as triethylamine, ethyl diisopropylamine or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran or dichloromethane. This transformation can also be accomplished by reacting a compound having formula (XXIII) with a compound having formula (XXIV) (where Y is Cl) and optionally a base such as triethylamine, ethyl diisopropylamine, or pyridine in a suitable solvent such as ethyl acetate, pyridine, or tetrahydrofuran. This transformation is depicted in Scheme 18.

[0282]

[0283] Compounds having formula (XXIII) can be produced by combining a compound having formula (II) (where X is Cl, Br, or I) and a compound having formula (XXV) (where any R is Cl, Br, or I). 7 Each of the following is independently hydrogen, C1-C6 alkyl, or two of the R groups. 7Together, they can form C3-C8 cycloalkyl groups, which are prepared by Suzuki cross-coupling in the presence of a base such as Cs2CO3, K2CO3, or NaOtBu and a suitable palladium catalyst such as tetra(triphenylphosphine)palladium, palladium dichloride, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), palladium acetate, or bis(diphenylphosphine)palladium(II) chloride, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water. This transformation is depicted in Scheme 19.

[0284]

[0285] Compounds having formula (V) and compounds having formula (XX) are prepared by known methods or are commercially available.

[0286] Compounds having formula (III) (where any R) 7 Each of the following is independently hydrogen, C1-C6 alkyl, or two of the R groups. 7 Together they can form C3-C8 cycloalkyl groups, which are prepared by known methods or are commercially available.

[0287] It should be understood that those skilled in the art will recognize that the amide coupling reactions described above between acids, amines, and coupling agents can also be carried out using the corresponding acyl chlorides and amines. The conversion of acids to their corresponding acyl chlorides is well known to those skilled in the art.

[0288] Alternatively, compounds of formula (I) according to the invention can be obtained using standard synthetic techniques known to those skilled in the art. Non-exhaustive examples include oxidation, reduction, hydrolysis, coupling, aromatic nucleophilic or electrophilic substitution, nucleophilic substitution, nucleophilic addition, olefination, oxime formation, alkylation, and halogenation.

[0289] Depending on the reaction conditions and the choice of starting materials appropriate to each situation, it may be possible, for example, to replace only one substituent with another substituent according to the invention in a single reaction step, or to replace multiple substituents with other substituents according to the invention in the same reaction step.

[0290] The present invention also provides intermediates that can be used to prepare compounds having formula (I) according to the present invention.

[0291] The following intermediates form another aspect of the present invention.

[0292] A compound having the formula (XXI)

[0293]

[0294] Where A is CH or N;

[0295] R 2a R 2b and R 2c Independently selected from H, hydroxyl, halogen, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl-C 1-4 Alkyl, C 1-6 Alkyl thioalkyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, C 1-6 Alkoxy, amino, and NHC(O)C 1-6 Alkyl; and preferably, R 2a R 2b and R 2c Independently selected from H, halogens, CN, C 1-4 Alkyl and C 1-4 Alkyl groups; and more preferably, R 2a Selected from H, C 1-6 Alkyl, C 3-6 cycloalkyl and C 1-6 Alkoxy-C 1-6 Alkyl, R 2b Selected from H, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 Alkyl, and R 2c It is H;

[0296] R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-6 Alkyl, C 1-6 Alkoxy C 1-6 Alkyl, C 1-6 Alkylamino, diC 1-6 Alkylamino, C 1-6 alkoxyamino, and C 1-6 Alkyl C 1-6 Alkoxyamino groups, wherein each of the groups is optionally substituted by one to three substituents independently selected from halogens and CN; preferably, R 6 Selected from C 1-4 Alkyl, C 1-4 Alkoxy, C 3-6 cycloalkyl and C 3-6 cycloalkyl-C 1-3Alkyl groups, wherein each of the groups is optionally substituted with one to three independent substituents selected from halogens; and preferably, R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino, C 1-6 alkoxyamino and C 1-6 Alkyl C 1-6 alkoxyamino; and

[0297] X is chlorine (Cl), bromine (Br), or iodine (I);

[0298] Or its salts or N-oxides.

[0299] The compositions according to the invention can be used in their unmodified form, or preferably, in conjunction with adjuvants conventionally used in the field of formulations. For this purpose, they can be conveniently formulated in known manner as emulsifiable concentrates, coated pastes, directly sprayable or dilutable solutions or suspensions, thin emulsions, wettable powders, soluble powders, dusts, granules, and also capsules (e.g., in polymeric forms). The method of application, such as spraying, atomizing, dusting, spreading, coating, or irrigating, is selected according to the intended purpose and the prevailing environment, depending on the type of composition. The compositions may also contain additional adjuvants, such as stabilizers, defoamers, viscosity modifiers, binders, or thickeners, in conjunction with fertilizers, micronutrient donors, or other formulations used to achieve specific effects.

[0300] Suitable carriers and / or adjuvants, for example for agricultural uses, can be solid or liquid and are substances useful in formulation techniques, such as natural or recycled minerals, solvents, dispersants, wetting agents, thickeners, binders, or fertilizers. Such carriers are described, for example, in WO 97 / 33890.

[0301] Suspension concentrates are aqueous formulations in which finely dispersed solid particles of an active compound are suspended. Such formulations contain anti-settling agents and dispersants, and may further contain wetting agents to enhance activity, as well as antifoamers and crystal growth inhibitors. When used, these concentrates are diluted in water and are typically applied as a spray to the area to be treated. The amount of active ingredient can range from 0.5% to 95% of the concentrate.

[0302] Wettable powders are finely dispersed granules that are easily dispersed in water or other liquid carriers. These granules contain active ingredients retained in a solid matrix. Typical solid matrices include bleaching clay, kaolin, silica, and other easily wettable organic or inorganic solids. Wettable powders typically contain 5% to 95% active ingredient plus small amounts of wetting agents, dispersants, or emulsifiers.

[0303] Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquids and may consist entirely of an active compound and a liquid or solid emulsifier, or may contain a liquid carrier such as xylene, heavy aromatic naphtha, isophorone, and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquids and are typically applied as a spray to the area to be treated. The amount of active ingredient can range from 0.5% to 95% of the concentrate.

[0304] Granular formulations consist of both extrudates and coarser granules, and are typically applied undiluted to the area requiring treatment. Typical carriers used in granular formulations include sand, bleaching clay, attapulgite clay, bentonite, montmorillonite, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, crushed corn cobs, crushed peanut shells, sugar, sodium chloride, sodium sulfate, sodium silicate, sodium borate, magnesium oxide, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulfate, and other organic or inorganic absorbent active compounds or materials that can be coated with active compounds. Granular formulations typically contain 5% to 25% of the active ingredient, which may include surfactants such as heavy aromatic naphtha, kerosene, and other petroleum fractions, or vegetable oils; and / or binders such as dextrin, gums, or synthetic resins.

[0305] Powdered agents are free-flowing mixtures of active ingredients and finely dispersed solids (such as talc, clay, flour, and other organic and inorganic solids that act as dispersants and carriers).

[0306] Microcapsules are typically droplets or particles of active ingredient encapsulated within an inert, porous shell that allows the encapsulated material to escape into the environment at a controlled rate. The diameter of the encapsulated droplets typically ranges from 1 to 50 micrometers. The encapsulated liquid typically constitutes 50% to 95% of the capsule's weight and may contain a solvent in addition to the active compound. The encapsulated particles are typically porous particles, with a porous membrane sealing the pores and retaining the active species in liquid form within the pores. The particle diameter typically ranges from 1 millimeter to 1 centimeter, and preferably from 1 millimeter to 2 millimeters. The particles are formed by extrusion, aggregation, or spheroidization, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust, and carbon concentrate. Shell or membrane materials include natural and synthetic rubbers, fibrous materials, styrene-butadiene copolymers, polyacrylonitrile, polyacrylates, polyesters, polyamides, polyureas, polyurethanes, and starch xanthates.

[0307] Other useful formulations for agrochemical applications include simple solutions of components A and B in a solvent (such as acetone, alkylated naphthalene, xylene, and other organic solvents) in which these components are completely dissolved at the desired concentration. Pressurized sprays can also be used, where the active ingredients are dispersed in a finely dispersed form due to the evaporation of the low-boiling-point dispersant solvent carrier.

[0308] Suitable agricultural adjuvants and / or carriers useful for formulating the compositions of the present invention among the above-described formulation types are well known to those skilled in the art.

[0309] Suitable liquid carriers include, for example, water, toluene, xylene, naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenyl, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetate, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol rosinate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl... Formamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, dipropylene glycol (diproxitol), alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, α-pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerol, glyceryl diacetate, monoethyl glycerol Ester, glyceryl triacetate, hexadecane, hexanediol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, cumene, isopropyl myristate, lactic acid, laurylamine, isopropylidene acetone, methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl lauryl ester, methyl octanoate, methyl oleate, dichloromethane, m-xylene, n-hexane, n-octylamine, stearic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, poly Ethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin wax, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols (such as pentanol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc.), ethylene glycol, propylene glycol, glycerol, and N-methyl-2-pyrrolidone. Water is usually the preferred carrier for diluting the concentrate.

[0310] Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, diatomaceous earth, chalk, lime, calcium carbonate, bentonite, bleaching clay, cottonseed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell powder, and lignin.

[0311] A wide range of surfactants are advantageously used in the liquid and solid compositions, especially those designed to be diluted with a carrier prior to application. These agents are typically used in amounts from 0.1% to 15% by weight of the formulation. They can be anionic, cationic, nonionic, or polymeric in nature and can be used as emulsifiers, wetting agents, suspending agents, or for other purposes. Typical surfactants include alkyl sulfates such as diethanolammonium lauryl sulfate; alkyl aryl sulfonates such as calcium dodecylbenzenesulfonate; alkylphenol-epoxide addition products such as nonylphenol-C.sub.18 ethoxylate; alcohol-epoxide addition products such as tridecyl alcohol-C.sub.16 ethoxylate; soaps such as sodium stearate; alkyl naphthalene sulfonates such as sodium dibutylnaphthalene sulfonate; salts of dialkyl sulfosuccinates such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters such as sorbitol oleate; quaternary ammonium compounds such as lauryltrimethylammonium chloride; polyethylene glycol esters of fatty acids such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and dialkyl phosphates.

[0312] Other adjuvants commonly used in agricultural compositions include crystallization inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, defoamers, opacifiers, compatibility agents, masking agents, neutralizers and buffers, corrosion inhibitors, dyes, flavor enhancers, spreading agents, penetration enhancers, micronutrients, softeners, lubricants, and fixatives.

[0313] The compositions of the present invention, including all the embodiments and preferred examples disclosed above, can be mixed with one or more other pest control agents, including additional fungicides, insecticides, nematicides, bactericides, acaricides, growth regulators, chemical sterilizers, chemical pheromones, insect repellents, attractants, pheromones, feeding stimulants, or other bioactive compounds to form multi-component pest control agents that provide broader-spectrum agricultural protection.

[0314] Examples of additional active ingredient components (C) are as follows, wherein the term "TX" refers to a compound selected from the compounds defined in Table X above or Table T1 below, specifically compounds numbered X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.16, X.17, X.18, X.19, X.20, X.21, X.22, or X.23 of the composition according to the invention (as defined in component (A)).

[0315] (7E,9Z)-Dodec-7,9-dien-1-yl acetate + TX, (9Z,11E)-Tetradec-9,11-dien-1-yl acetate + TX, (9Z,12E)-Tetradec-9,12-dien-1-yl acetate + TX, (E)-6-methylhept-2-en-4-ol + TX, (E)-dec-5-en-1-yl acetate and (E)-dec-5-en-1-ol + TX, (E)-Tedec-4-en-1-yl acetate + TX, (E,Z)-Tetradec-4,10-dien-1-yl acetate + TX, (Z)-Dodec-7-en-1-yl acetate + TX, (Z) - Hexadec-11-en-1-yl acetate + TX, (Z)-hexadec-11-enal + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate + TX, (Z)-eicosero-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-tetradec-9-en-1-ol + TX, (Z)-tetradec-9-en-1-yl acetate + TX, 1,2-dibromo-3-chloropropane + TX, 1,2-dichloropropane + TX, 1,2-dichloropropane and 1,3-dichloropropene + TX, 1,3-dichloropropene + TX, 14-methyloctadec-1-ene + TX 1-H-hydroxy-1H-pyridine-2-thione + TX, 2-(octylthio)ethanol + TX, 2-chlorophenyl N-methylcarbamate (CPMC) + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide + TX, 4-(quinoxalo-2-ylamino)benzenesulfonamide + TX, 4-methylnon-5-ol and 4-methylnon-5-one + TX, 5-methyl-6-thio-1,3,5-thiadiazin-3-ylacetic acid + TX, 6-isopentenylaminopurine + TX, 8-hydroxyquinoline sulfate + TX, avermectin + TX, miticide quinone + TX, acetamiprid + TX Acetaminophen + TX, flufenoxuron + TX, acynonapyr + TX, Cotton Brown Leaf Roller GV + TX, Bifenthrin + TX, Afoxolaner + TX, Agrobacterium radiata + TX, AKD-3088 + TX, Cotton Bollworm + TX, Aldicarb + TX, Aldoxycarb + TX, Propyrethroid + TX, Cis-cypermethrin + TX, High-efficiency cypermethrin + TX, Alpha-multistriatin + TX, Amblyseius spp. + TX, Sulfamethrin + TX, Amino acids + TX, Mefenoxam + TX, Celery Earworm NPV + TX, Anagris atomus + TX, Aphelinus abdominalis + TXAphidius colemani + TX, Aphidoletes aphidimyza + TX, apholate + TX, alfalfa silver-striped moth NPV + TX, AZ 60541 + TX, azadirachtin + TX, triazole tin + TX, Bacillus aizawai + TX, Bacillus chitinosporus AQ746 (NRRL registry number B-21) 618)+TX, Bacillus sphaericus+TX, Bacillus sphaericus Kurstaki+TX, Bacillus mycosis fungoides AQ726 (NRRL accession B-21664)+TX, Bacillus pumilus (NRRL accession B-30087)+TX, Bacillus pumilus AQ717 (NRRL accession B-21662)+TX, Bacillus species AQ175 (ATCC accession 55608)+TX, Bacillus species AQ177 (ATCC accession 55609)+TX, Bacillus species AQ178 (ATCC accession 53522)+TX, Bacillus sphaericus Neide)+TX, Bacillus subtilis AQ153 (ATCC accession number 55614)+TX, Bacillus subtilis AQ30002 (NRRL accession number B-50421)+TX, Bacillus subtilis AQ30004 (NRRL accession number B-50455)+TX, Bacillus subtilis AQ713 (NRRL accession number B-21661)+TX, Bacillus subtilis AQ743 (NRRL accession number B-21665)+TX, Unspecified Bacillus subtilis+TX, Bacillus thuringiensis AQ52 (NRRL accession number B-21619)+TX, Bacillus thuringiensis BD#32 (NRRL accession number B-21530)+TX, Bacillus thuringiensis Bacillus thuringiensis (Berberer) + TX, Bacillus thuringiensis subsp. Aizawai + TX, Bacillus thuringiensis subsp. Israelensis + TX, Bacillus thuringiensis subsp. Japonensis + TX, Bacillus thuringiensis subsp. Kurstaki + TX, Bacillus thuringiensis subsp. Tenebrionis + TX, Bacillus thuringiensis subsp. Kurstaki BMP 123 + TX, Beauveria bassiana + TX, Beauveria brongniartii + TX,Benclothiazide + TX, benomyl + TX, chlorpyrifos + TX, fenpropathrin + TX, benzpyrimoxan + TX, β-cypermethrin + TX, β-cypermethrin + TX, bethoxazin + TX, bifenazate + TX, bifenthrin + TX, chlorfenapyr + TX, bio-allethrin + TX, bio-benzylfenozide + TX, bis(tributyltin)oxide + TX, bis(aziridine)methylphosphonic acid sulfide + TX, bis(triflufenoxuron) + TX, flufenoxuron + TX, brevicomin + TX, broflanilide + TX Bromofluoromethyl + TX, Bromoacetamide + TX, Bromothion-Ethyl + TX, Bromonitol + TX, Busulfan + TX, Butanone + TX, Butopyronoxyl + TX, Butoxyl (polypropylene glycol) + TX, Butylpyridaben + TX, Cadusafos + TX, Calcium Arsenate + TX, Carbaryl + TX, Carbon Disulfide + TX, Butylcarbofuran + TX, Bataan + TX, CAS No.: 1594624-87-9 + TX, CAS No.: 1922957-47-8 + TX, CAS No.: 1255091-74-7 + TX, CAS No.: 1365070-72-9+TX, CAS No.: 1445683-71-5+TX, CAS No.: 1445684-82-1+TX, CAS No.: 1594626-19-3+TX, CAS No.: 1594637-65-6+TX, CAS No.: 1632218-00-8+TX, CAS No.: 1808115-49-2+TX, CAS No.: 1922957-46-7+TX, CAS No.: 1922957-48-9+TX, CAS No.: 1956329-03-5+TX, CAS No.: 1990457-52-7+TX, CAS No.: 1990457-55-0+TX, CA CAS No.: 1990457-57-2+TX, CAS No.: 1990457-66-3+TX, CAS No.: 1990457-77-6+TX, CAS No.: 1990457-85-6+TX, CAS No.: 2032403-97-5+TX, CAS No.: 2044701-44-0+TX, CAS No.: 2095470-94-1+TX, CAS No.: 2128706-04-5+TX, CAS No.: 2128706-05-6+TX, CAS No.: 2133042-31-4+TX, CAS No.: 2133042-44-9+TX, CAS No.: 2171099-09-3+TXCAS No.: 2220132-55-6+TX, CAS No.: 2396747-83-2+TX, CAS No.: 2408220-91-5+TX, CAS No.: 2408220-94-8+TX, CAS No.: 2415706-16-8+TX, Piperflanilide (CAS No.: 2615135-05-0)+TX, CAS No.: 2719848-60-7+TX, CAS No.: RNA (Potato Beetle-Specific Recombinant Double-Stranded Interference GS2)+TX, Chlorpyrifos Benzamide + TX, Chlordane + TX, Bromnipotentiol + TX, Chlorothalonil + TX, Cypermethrin + TX, Chlorpyrifos + TX, Cyclofenac + TX, Chrysoperlacarnea + TX, Clenbuterol + TX, Dimethoate + TX, Thiamethoxam + TX, Codlelure + TX, Codlemone + TX, Copper arsenite + TX, Copper dioctanoate + TX, Copper hydroxide + TX, Copper sulfate + TX, Cresol + TX, Phosphorus + TX, Cryptolaemus montrouzieri + TX, cuelure + TX, benzyl phosphate + TX, broflanilide + TX, cybutryne + TX, cyclobutrifluram + TX, pyrethroid + TX, epoxim + TX, codling moth GV + TX, pyridaben + TX, cyetpyrafen + TX, diflubenzuron + TX, lambda-cyhalothrin + TX, cyhalothrin + TX, deltamethrin + TX, cyproflanilide + TX, cyromazine + TX, cytokinin + TX, Dacnusa Sibirica + TX, Dazomet + TX, DBCP + TX, DCIP + TX, Deltamethrin + TX, Acaricide + TX, Chlorimide + TX, Diamidafos + TX, Dibromide + TX, Dibutyl Adipate + TX, Dibutyl Phthalate + TX, Dibutyl Succinate + TX, Acaricide + TX, Dichloronaphthoquinone + TX, Dichlorophenol + TX, Didicophos + TX, Dichlorvos + TX, DEET + TX, Diflubenzuron + TX, Diglyphusisaea + TX, Dimatif + TX, Dimethoate + TX, Dimethyl Carbate + TX, Dimethyl Phthalate + TXDimpropyridaz + TX, Dichlorvos + TX, Acaricide + TX, Fipronil + TX, Pyrimethanil + TX, Dipyridamole + TX, Disparlure + TX, D-Limonene + TX, Dodecano-8-en-1-ylacetate + TX, Dodecano-9-en-1-ylacetate + TX, Dodecano-8,10-dien-1-ylacetate + TX, Dodecylene + TX, Dominicalure + TX, Dolactin + TX, Emamectin + TX, Emamectin Benzoate + TX, Dextromethorphan + TX, Encarsia formosa + TX, Indomethacin + TX, Iridilamide + TX, Irinocin + TX, Epsilon-momfluorothrin + TX, Epsilon-methoxybenzylflumethin + TX, Eretmocerus eremicus)+TX, cypermethrin+TX, ethionine+TX, acetamiprid+TX, ethoprofen+TX, ethyl 4-methyloctanoate+TX, ethylhexane glycol+TX, dibromoethane+TX, permethrin+TX, etoxazole+TX, etpyrafen+TX, eugenol+TX, seaweed extract and fermentation products derived from saccharyl +TX, seaweed extract and fermentation products derived from saccharyl (including urea)+TX, seaweed extract and fermentation products... Plant products + TX, seaweed extracts and fermented plant products (including plant hormones, vitamins, EDTA chelated copper, zinc, and iron) + TX, phosmet + TX, sodium dichloroisocyanurate + TX, fenamiphos + TX, quinalox + TX, pendimethalin + TX, fenitrothion + TX, fenmezoditiaz + TX, methyl parathion + TX, fenthiocarb + TX, fenoxycarb + TX, cypermethrin + TX, fenpyrad. +TX, azoxystrobin +TX, fenpropathrin +TX, fenthion +TX, triphenyltin +TX, cypermethrin +TX, ferric phosphate +TX, fipronil +TX, fometoquin +TX, flupyridine +TX, pyrimethanil +TX, trifluoperamide +TX, pyridaben +TX, flufenoxuron +TX, flufenoxuron +TX, flucitrinate +TX, flufenoxuron +TX, flufenoxuron +TX, flufenoxuron +TX, flufenoxuron Fenfenpyroxene + TX, fluensulfone [318290-98-1] + TX, fluensulfone + TX, pyrimethanil + TX, trifluralin + TX, fipronil + TX, fluhexafon + TX, flupyroxystrobin + TX, fluopyram + TX, flupyroxystrobin + TX,Fluralaner + TX, cypermethrin + TX, fluxametamide + TX, formaldehyde + TX, fosthiazate + TX, fosthietan + TX, frontalin + TX, furfural + TX, γ-cyhalothrin + TX, (A 1:1 mixture of (Z,E) and (Z,Z) isomers of hexadecyl-7,11-dien-1-yl-acetate) + TX, Grandlure + TX, Grandlure I + TX, Grandlure II + TX, Grandlure III + TX, Grandlure IV + TX, Particulate Virus + TX, Pendimethalin + TX, GY-81 + TX, Benzylfentanyl + TX, Chlorfenapyr + TX, Kangzhuang Harpin + TX, Cotton bollworm nucleopolyhedrovirus + TX, Millettia oblatina NPV + TX, Millettia oblatina nucleopolyhedrovirus + TX, Australian cotton bollworm nucleopolyhedrovirus + TX, Tobacco budworm nucleopolyhedrovirus + TX, Hemel + TX, Hempa + TX, Heptamethrin + TX, Phosphate + TX, Heterorhabditis bacteriophora and H. megidis + TX, Hexalure + TX, Hexamide + TX, Thiamethoxam + TX, Hippodamia convergens+TX, flufenoxuron+TX, mercaptan+TX, quicklime+TX, imidacloprid+TX, imidacloprid+TX, pyrethroids+TX, indazapyroxamet+TX, indoxacarb+TX, iodomethacin+TX, iprodione+TX, ipsdienol+TX, ipsenol+TX, isamidophos+TX, chlorpyrifos+TX, isoxaflutole+TX ycloseram+TX, Isoflualanam (CAS No.: 2892524-05-7)+TX, isopyram+TX, ivermectin+TX, japonilure sex pheromone+TX, κ-bifenthrin+TX, κ-heptafluthrin+TX, kasugamycin+TX, kasugamycin hydrochloride hydrate+TX, kinetin+TX, lambda-cyhalothrin+TX, ledprona+TX, resveratrol+TX, Leptomastix parasitic wasp dactylopii)+TX, trimethyldioxane (lineatin)+TX, litlure (little moth attractant)+TX, looplure (powdery armyworm pheromone attractant)+TX, lotilaner (lotilaner)+TX, clofenuron+TX, macrorolophus (caliginosus)+TX, cabbage armyworm NPV+TX, mecarphon+TX, medlure+TX, megatomoic acid (montmorillonite)acid)+TX, cyfluthrin+TX, metaldehyde+TX, thiamethoxam+TX, thiamethoxam potassium salt+TX, thiamethoxam sodium salt+TX, Metaphycus helvolus+TX, Metarhizium anisopliae var. acridum+TX, Metarhizium anisopliae var. anisopliae+TX, Metarhizium species+TX, methyl thiamethoxam+TX, methomyl+TX, methiotepa+TX, methomyl+TX, methoquin-butyl+TX, methoxyfenozide+TX, methyl apholate+TX, methyl bromide+TX, methyl phosphonate (methyl phosphonate) ... Eugenol + TX, Methyl isothiocyanate + TX, Methylneodecanamide + TX, Methoxyfenozide + TX, Cypermethrin + TX, Cypermethrin + TX, Acaricide + TX, Milbemazole + TX, Momfluorothrin + TX, Morzid + TX, Moxifloxacin + TX, Muscalure + TX, Muscodor albus 620 (NRRL Registry No. 30547) + TX, Muscodor roseus A3-5 (NRRL Registry No. 30548) + TX, Varicella vesicola composition + TX, Sodium mancozeb + TX, NC-184 + TX, Neem-based products + TX, NeodiprionN. lecontei NPV and N. lecontei NPV+TX, bis(dimethyldithiocarbamate)nickel+TX, nicofluprole+TX, nicofluprole-ethanolamine+TX, acetamiprid+TX, nitenpyram+TX, trichloromethylpyridine+TX, octadec-2,13-dien-1-yl acetate+TX, octadec-3,13-dien-1-yl acetate+TX, octathiazone+TX, omethoate+TX, orfralure+TX, species of the genus *N. lecontei* + TX. TX, oryctalure + TX, ostramone + TX, oxamate + TX, oxazosulfyl + TX, oxazosulfonic acid + TX, oxytetracycline + TX, Paecilomyces lilacinus + TX, parathion-ethyl + TX, Pasteurella multocida + TX, Pasteurella punctata + TX, Pasteurella mycoides + TX, Pasteuria thornei + TX, Pasteurella + TX, p-cymene + TX, penfluron + TX, pentachlorophenol + TX, permethrin + TX, fenpropathrin + TX, phorate + TX, phosphatidylcholine + TX, phosphocarb + TX, Phytoseiulus persimilis + TX, picaridin + TX, pioxaniliprole + TX, piperazine + TX, piperidine + butyl ether + TX, pirimicarb + TX, pyrimidine phosphonate-ethyl + TX, pyrimidine phosphonate-methyl + TX, diamondback moth granulovirus + TX, diamondback moth nucleopolyhedrovirus + TX, polyhedrovirus + TX, potassium and molybdenum and EDTA chelated manganese + TX, potassium ethyl xanthate + TX, potassium hydroxyquinoline sulfate + TX, pyrethroid + TX, thiamethoxam + TX, profenofos + TX, fenflurphos + TX, chlorfenapyr + TX, acetamiprid + TX, propoxur + TX, thiophanate-methyl + TX Protrifenbute + TX, pyflubumide + TX, pymetrozine + TX, pyrafluprole + TX, pyrethrum + TX, pyridaben + TX, acetamiprid + TX, pyridinium-4-amine + TX, pyrifluquinazon + TX, pyrifluquinazon + TX, pyriminostrobin + TX, pyrazosulfan [394730-71-3] + TX, pyrazosulfan + TX, fenvalerate + TX, QRD 420 (terpene blend) + TX, QRD452 (terpene blend) + TX, QRD460 (terpene blend) + TX, soapberry + TX, quinoclamine + TX, quinonamid + TX, benzylfuran + TX, Rhodococcus aureus AQ719 (NRRL registration number B-21663) + TX, sarolaner + TX, S-bioallethrin + TX, sebufos + TX, silaketin + TX, insecticidal ring (si glure + TX, flusilazole + TX, simazine + TX, sodium pentachlorophenate + TX, sordidin + TX, spiroxamat + TX, spinosad + TX, spinosad + TX, spirobudifen + TX, spirodiclofen + TX, spirodiclofen + TX, spiropidion + TX, spirodiclofen + TX, beet armyworm nucleopolyhedrovirus (Spodoptera Exigua multicapsid nuclear polyhedrosis virus (TX), fall armyworm nucleopolyhedrovirus (TX), Steinernema bibionis (TX), Steinernema carpocapsae (TX), Steinernema noctuid moth (TX), Steinernema glaseri (TX), Steinernema riobrave (TX), Steinernema riobravis (TX), Steinernema scapterisci (TX), Steinernema spp. (TX), Streptomycesgalbus (NRRL Registry No. 30232) + TX, Streptomyces species (NRRL Registry No. B-30145) + TX, Streptomycin + TX, Streptomycin Sesquisulfate + TX, Strychnine + TX, Sulcatol + TX, Sulfiflumin (CAS No.: 2377084-09-6) + TX, Sulfadiazine + TX, Tazimcarb + TX, Tebufenozide + TX, Pyridaben + TX, Tebufenozide + TX, Tebufenozide + TX, Phosphatidylcholine + TX, Cypermethrin + TX, Dithion + TX, Tepa + TX, Terbam + TX Terbufos + TX, Terpene Blend + TX, Tetrachlorantraniliprole + TX, Tetrachlorothiophene + TX, Tetradec-11-en-1-ylacetate + TX, Tetrachlordrimone + TX, Aspergillus + TX, Tetrafluthrin + TX, Acaricide + TX, Flufenoxuron + TX, θ-Cypermethrin + TX, Thiafenox + TX, Thiamethoxam + TX, Cypermethrin + TX, Thiamethoxam + TX, Thiamethoxam + TX, Thiamethoxam + TX, Thiamethoxam + TX, Thiohempa + TX, Thimerosal + TX, Methyl phorate + TX , including nematicide + TX, thiophanate-methyl + TX, chlorpyrifos + TX, thiophanate-methyl + TX, tigolaner + TX, tiorantraniliprole + TX, tioxazafen + TX, azithromycin + TX, toxaphene + TX, tetrabromopyrethrin + TX, tratamidophos + TX, pymetrozine + TX, triazophos + TX, triazolium + TX, trichlorfon + TX, phorate + TX, trichlorphon + TX, Trichogrammae + TX species, and trifon. Enmorph + TX, Trifluenfuronate + TX, Triflumezopyrim + TX, Trimedlure + TX, Mediterranean fruit fly attractant A + TX, Mediterranean fruit fly attractant B1 + TX, Mediterranean fruit fly attractant B2 + TX, Mediterranean fruit fly attractant C + TX, Trimethacarb + TX, Triphenyltin acetate + TX, Triphenyltin hydroxide + TX, Trunc-call + TX, Tyclopyrazoflor + TX, Typhlodromusoccidentalis)+TX, urethaneimine+TX, Verticillium lecanii+TX, Verticillium species+TX, xylenol+TX, YI-5302+TX, zeatin+TX, ζ-cypermethrin+TX;

[0316] N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methylformamidinium (these compounds can be prepared by the method described in WO 2019 / 110427) + TX, (3',4',5'-trifluoro-biphenyl-2-yl)-amide + TX, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ketone (these compounds can be prepared by ... The compound can be prepared by the method described in WO 2017 / 220485) + TX, 2-amino-6-methyl-pyridine-3-carboxylic acid (4-phenoxyphenyl) methyl ester (this compound can be prepared by the method described in WO 2014 / 006945) + TX, (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] ketone + TX, (7E,9Z)-dodecano-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradecano-9,11-dien-1-yl acetate + TX, (9Z,1) 2E)-Tetradec-9,12-dien-1-yl acetate + TX, (E)-6-methylhept-2-en-4-ol + TX, (E)-dec-5-en-1-yl acetate and (E)-dec-5-en-1-ol + TX, (E)-tetrate-4-en-1-yl acetate + TX, (E,Z)-tetradec-4,10-dien-1-yl acetate + TX, (R)-3-( (Z)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazol-4-carboxamide + TX, (Z)-dodec-7-en-1-yl acetate + TX, (Z)-hexadec-11-en-1-yl acetate + TX, (Z)-hexadec-11-enal + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate + TX, (Z)-eicoseno-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-tetradec-9-en-1-ol + TX, (Z)-tetradec-9-en-1-yl acetate + TX, (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamine (this compound can be derived from WO The method described in 2018 / 153707 is used to prepare (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamine + TX.[2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]thiazo-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro-phenyl]methanesulfonate + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline (these compounds can be derived from WO4) The method described in 2017 / 025510 prepares TX, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol + TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane + TX, 1,2-dibromo-3-chloropropane + TX, 1,2-dichloropropane and 1,3-dichloropropene + TX, 1,3-dichloropropene + TX, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- [4-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazole-5-one+TX, 10-dien-1-yl acetate+TX, 14-methyloctadec-1-ene+TX, 1-bromo-2-chloroethane+TX, 1-dichloro-1-nitrobethanone+TX, 1-hydroxy-1H-pyridine-2-thione+TX, 1-methoxy-3-methyl-1-[[4] -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea+TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazole-5-one+TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide+TX, 2-(difluoromethyl)-N-((3R)-1 1,3-Trimethylindan-4-yl)pyridine-3-carboxamide + TX, 2-(1,3-dithiopentane-2-yl)phenyl dimethyl carbamate + TX, 2-(2-butoxyethoxy)ethyl piperine + TX, 2-(2-butoxyethoxy)ethyl thiocyanate + TX, 2-(4,5-dimethyl-1,3-dioxolane-2-yl)phenyl methyl carbamate + TX, 2-(4-chloro-3,5-dimethylmethyl)ethanol + TX,2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indane-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indane-4-yl]pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl-indane-4-yl]pyridine-3-carboxamide (this compound can be derived from WO4) The method described in 2014 / 095675 is used to prepare TX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 2-(octylthio)ethanol + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate + TX, 2,2-dichlorovinyl-2-ethylsulfinyl ethyl methyl phosphate + TX, 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + TX, 2,4-dichlorophenylbenzenesulfonate + TX, 2,6-dimethyl-1H,5H-[1,4]dithiacino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraone (this compound can be prepared by WO The compound can be prepared by the method described in WO 2011 / 138281) + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolinyl)oxy]phenyl]prop-2-ol + TX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)prop-2-ol (this compound can be prepared by the method described in WO 2017 / 029179) + TX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)prop-2-ol (this compound can be prepared by WO 2017 / 029179) + TX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)prop-2-ol (this compound can be prepared by WO 2017 / 029179) The following compounds can be prepared by the method described in WO 2017 / 029179: 2-chlorovinyl diethyl phosphate + TX, 2-fluoro-N-methyl-N-1-naphthylacetamide + TX, 2-imidazolinone + TX, 2-isovaleryl indan-1,3-dione + TX, 2-methyl(prop-2-ynyl)aminophenyl methyl carbamate + TX, 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (this compound can be prepared by the method described in WO 2018 / 065414) + TX, 2-cyanothioethyl laurate + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolinyl)-7,8-dihydro-6H-cyclopentadieno[e]benzimidazole (these compounds can be prepared by WO 2018 / 065414) + TX, 2-cyanothioethyl laurate + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolinyl)-7,8-dihydro-6H-cyclopentadieno[e]benzimidazole (these compounds can be prepared by WO 2018 / 065414) + TX. The method described in 2016 / 156085 is used to prepare 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinoline-1-yl)quinolone + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX,3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide + TX, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]imidazolium-4-carboxylonitrile (this compound can be prepared by the method described in WO2016 / 156290) + TX, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]imidazolium-4-carboxylonitrile (this compound can be prepared by the method described in WO2016 / 156290) + TX, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]imidazolium-4-carboxylonitrile (this compound can be prepared by WO2016 / 156290) + TX The methods described in 2016 / 156290 are used to prepare TX, 3-bromo-1-chloroprop-1-ene, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-methyl-1-phenylpyrazole-5-yl dimethylcarbamate, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro- 6-Fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazin-3-carboxynitrile + TX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-2,5-dimethyl-pyrazole-3-amine + TX, 4-(quinoxalo-2-ylamino)benzenesulfonamide + TX, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazol[ 1,5-a]pyridine-3-yl)isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridine-3-yl)isoquinoline + TX, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isooxazolidine-3-one + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2- (2,4-Difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioalkyl-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thio-4H-1,2,4-triazol-1-yl)phenyl]-3-pyridyl]oxy]benzonitrile + TX, 4-chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazine-3-one + TX, 4-chlorophenylphenyl sulfone + TX4-Methyl(prop-2-ynyl)amino-3,5-dimethylmethylcarbamate + TX, 4-methylnon-5-ol and 4-methylnon-5-one + TX, 5-(1,3-benzodioxane-5-yl)-3-hexylcyclohex-2-enone + TX, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidine-3-one + TX, 5,5-di Methyl-3-oxocyclohexyl-1-enyl dimethyl carbamate + TX, 5-amino-1,3,4-thiadiazol-2-thiol zinc salt (2:1) + TX, 5-methyl-6-thio-1,3,5-thiadiazin-3-ylacetic acid + TX, 6-chloro-3-(3-cyclopropyl-2-fluoro-phenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methyl-pyridazine-4-carboxamide (can be made from WO The following ingredients are prepared by the method described in WO 2020 / 109391: 6-chloro-3-(3-cyclopropyl-2-fluoro-phenoxy-N-[2-(3,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methyl-pyridazin-4-carboxamide (which can be prepared by the method described in WO 2020 / 109391) + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + TX, and 6-chloro-N-[2-(2-chloro-4-methyl-phenyl)-2,2-difluoro-ethyl]-3-(3-cyclopropyl-2-fluoro-phenoxy)-5-methyl-pyridazin-4-carboxamide (which can be prepared by the method described in WO 2020 / 109391) + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + TX, 6-chloro-N-[2-(2-chloro-4-methyl-phenyl)-2,2-difluoro-ethyl]-3-(3-cyclopropyl-2-fluoro-phenoxy)-5-methyl-pyridazin-4-carboxamide (which can be prepared by WO 2020 / 109391) + TX. The preparation methods described in 2020 / 109391 include: TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithiazo[1,2-c]isothiazolyl-3-carboxynitrile, 6-isopentenylaminopurine, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, and 8-hydroxyquinoline sulfate. Aspergillus + TX, Acetaminophen + TX, Acibenzolar + TX, Acibenzolar-S-methyl + TX, Acrylonitrile + TX, Cotton Brown Leaf Roller GV + TX, Agrobacterium radiata + TX, Aldoxycarb + TX, Aldrin + TX, Alpromethazine + TX, Dimethomorph + TX, α-Chlorohydrin + TX, α-Decidin + TX, α-Multistriatin + TX, Aluminum phosphide + TX, Amblyseius spp. + TX, Amectotractin + TX, Azoxystrobin + TX, Cypermethrin + TX, Phosphorus + TX, Dimethomorph + TXAminopyrifen + TX, indazole + TX, phosmet + TX, phosmet + TX, amitraz + TX, neonicotinoid + TX, celery cutworm NPV + TX, *Anagrus atomus* + TX, pyrimidinol + TX, difenoconazole + TX, anisiflupurin + TX, anthraquinone + TX, antagonist + TX, short-spur aphid wasp + TX, cotton aphid parasitic wasp + TX, aphid gall midge + TX, apholate + TX, acaricide + TX, arsenic trioxide + TX, ethyl chlorpyrifos + TX, alfalfa silver-striped cutworm NPV + TX, azaconazole + TX, methyl pyridaben + TX, azobenzene + TX, azophos + TX, pyraclostrobin + TX, Bacillus sphaericus Neide+TX, Bacillus thuringiensis δ-endotoxin+TX, Barium carbonate+TX, Barium hexafluorosilicate+TX, Barium polysulfide+TX, Cypermethrin+TX, Bayer 22 / 190+TX, Bayer 22408+TX, Beauveria bassiana brongniartii)+TX, benalaxyl+TX, benclothiaz+TX, benomyl+TX, benoxaphos+TX, benoxafos+TX, benthiamethoxam+TX, benthiamethoxam+TX, benzoflubenzuron+TX, benzyl benzoate+TX, β-cypermethrin+TX, β-cypermethrin+TX, bethoxazin+TX, bioethanomethrin+TX, biopermethrin+TX, bis(2-chloroethyl) ether+TX, bis(tributyltin) oxide+TX, bis(azir)methylphosphonic acid sulfide+TX, bismuth subtilis+TX, bifenazine+TX, bifenthrin-S+TX, borax+TX, borax Multi-mixed agent + TX, boscalid + TX, brevicomin + TX, bromadiolone + TX, bromodimethalin + TX, bromadiolone + TX, bromadiolone + TX, bromobenzene + TX, bromoacetamide + TX, bromodimethalin + TX, bromo-DDT + TX, bromothion + TX, bromodimethalin + TX, furazolidone + TX, bromonitrothion + TX, styrax + TX, bupirimate + TX, thiamethoxam + TX, busulfan + TX, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, chlorpyrifos + TX, butathiofos + TX, methyl ethyl ketone + TX, butyl ester + TX,Butopyronoxyl + TX, Butoxyl (polypropylene glycol) + TX, Butanone sulfonate + TX, Butylpyridinium + TX, Calcium arsenate + TX, Calcium cyanide + TX, Calcium polysulfide + TX, Camphene octachlorophene + TX, Captan + TX, Carbendazim + TX, Chlorpyrifos + TX, Carbendazim + TX, Carbon disulfide + TX, Carbon tetrachloride + TX, Phosphate + TX, Carbendazim + TX, Carbendazim + TX, Bataan + TX, CAS No.: 2132414-04-9 + TX, CAS No.: 2344721-61-3 + TX, Cevadine + TX, Acaricide + TX, Chloraldehyde + TX, Acaricide + TX, Borneol + TX Chlordane + TX, decachlorfenapyr + TX, amitraz + TX, amitraz hydrochloride + TX, dicofol + TX, dicofol + TX, difenoconazole + TX, ethyl dicofol + TX, chloroform + TX, chloroindolehydrazine + TX, chloromebuform + TX, diflubenzuron + TX, chloroneb + ​​TX, chlorpyrifos + TX, chloropicrin + TX, propyl dicofol + TX, chlorothalonil + TX, chlorpyrifos + TX, chlorpyrifos + TX, chlorfenapyr + TX, chlozolinate + TX, cholecalciferol + TX, common lacewing (Chrysoperla) Carnea + TX, Cucurbitacin I + TX, Cucurbitacin II + TX, Cucurbitacin + TX, Cismethrin + TX, Cis-resmethrin + TX, Clocythrin + TX, Clostridium + TX, Codlelure + TX, Codlemone + TX, Copper arsenite + TX, Copper arsenate + TX, Copper dioctanoate + TX, Copper hydroxide + T X, Copper naphthenate + TX, Copper oleate + TX, Copper oxide + TX, Copper oxychloride + TX, Copper sulfate + TX, Chlorpyrifos + TX, Rat parathion + TX, Phosphate + TX, Naphthalene + TX, Jiaxiangjunzhi + TX, Coumithoate + TX, Eugenol + TX, Pyrimidine + TX, Clomidon + TX, Phosphate + TX, Phosphate + TX, Cryolite + TX, Cryptolaemus Montrouzieri + TX, CS 708 + TX, Cuelure + TX, Thiazol + TX, Benzoate + TX, Fenoxacloprid + TX, Phoxim + TX, Cyazofamid + TX, Cybutryne + TX, Cypyrethrum + TX, Cyclobutrifluram + TX, Codling moth GV + TX, Cyfluthrin + TX, Acaricide + TXCymoxanil + TX, Cycloazolomide + TX, Azoxystrobin + TX, Cymoxanil + TX, Cytokinin + TX, Dacnusa sibirica + TX, DAEP + TX, Dazomet + TX, DCIP + TX, DCPM + TX, DDT + TX, Debacarb + TX, Decarbofuran + TX, Demeton-S-methyl + TX, Demeton-O + TX, Demeton-O-methyl + TX, Demeton-S+TX, Demeton-S-methyl + TX, Demeton-S-methylsulfon + TX, Diamidafos + TX, Dibutyl adipate + TX, Dibutyl phthalate +TX, dibutyl succinate +TX, isochlorpyrifos +TX, dichlobentiazox +TX, chlorpyrifos +TX, bactericide +TX, dichloronaphthoquinone +TX, dichlorophenol +TX, dichlorvos +TX, dichlozoline +TX, diliphos +TX, diclocymet +TX, diclomezine +TX, dicloran +TX, dicresyl +TX, cyclopyrrolidone +TX, dicyclopentadiene +TX, dieldrin +TX, acaricide +TX, diethofencarb +TX Diethyl-5-methylpyrazol-3-yl phosphate + TX, DEET + TX, Difenoconazole + TX, Thiamethoxam + TX, Flufenoxam + TX, Diglyphusisaea + TX, Dilor + TX, Dimatif + TX, Tetrafluoromethrin + TX, Mefenoxam + TX, Dimethoate + TX, Dimethoate + TX, Dimethoate + TX, Dimethoate + TX, Dimethoate + TX, Dimethylcarbate + TX, Dimethyl phthalate + TX, Methylpyridinium chloride + TX, Difenoconazole + TX, Azoxystrobin + TX, and other insecticides. Dinex + TX, Dinex-diclexine + TX, Tebuconazole + TX, Difenoconazole-4 + TX, Difenoconazole-6 + TX, Alpha-D + TX, Amyl nitrate + TX, Propnitrophenol + TX, Pentyl nitrate + TX, Diphenoxyacetic acid + TX, Oxyl nitrate + TX, Nitrobutyl nitrate + TX, Benzyl ether + TX, Phosphate + TX, Dichlorvos + TX, Ratnitrile + TX, Sulfonyl diphenyl + TX, Dipymetitrone + TX, Dipyridamole + TX, Disparlure + TX, Dithianon + TX, Thiamethoxam + TX, DNOC + TXDodecyl-8-en-1-yl acetate + TX, Dodecyl-9-en-1-yl acetate + TX, Dodecyl-8 + TX, Dodecylmorpholine + TX, Dodecyl + TX, Dodecyl + TX, Dofenapyn + TX, Dominicalure + TX, Dolactin + TX, DSP + TX, d-methoxyphenoxyacetate + TX, Ecstatone + TX, Kebensan + TX, EI 1642 + TX, EMPC + TX, Encarsia formosa + TX, Indomethacin + TX, Indomethacin + TX, Enoxastrobin + TX, Enoxastrobin + TX, EPBP + TX, Flutriafol + TX, Irinoctin + TX, Eretmocerus eremicus)+TX, calciferol+TX, etaphos+TX, ethaboxam+TX, ethimide+TX, ethirimol+TX, thiamethoxam+TX, 1-[[4-[(Z)-2-ethoxy-3,3,3-trifluoro-prop-1-enoxy]phenyl]methyl]pyrazole-3-carboxylic acid ethyl ester (which can be prepared by the method described in WO 2020 / 056090)+TX, 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolane-2-yl]methoxy]phenyl]methyl]pyrazole-3-carboxylic acid ethyl ester (which can be prepared by ... Prepared by the method described in 2020 / 056090) + TX, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate ethyl ester + TX, 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate ethyl ester (this compound can be prepared by WO The following compounds were prepared by the method described in 2018 / 158365: ethyl 4-methyloctanoate + TX, ethyl formate + TX, ethylhexane glycol + TX, dibromoethane + TX, dichloroethane + TX, ethylene oxide + TX, etridiazole + TX, ethirimol + TX, eugenol + TX, EXD + TX, oxadixyl + TX, farnesol + TX, farnesol with nerol + TX, fenamidone + TX, sodium dichloroisocyanurate + TX. Azoxystrobin + TX, chlorpyrifos + TX, fenpropathrin + TX, fenbutatin + TX, phosmet + TX, ethylcarbendazim + TX, mefenoxamyl + TX, cyclophosphamide + TX, fenitrothion + TX, fenthiocarb + TX, fenoxamil + TX, fenoxamil + TX, seed dressing + TX, fenpicoxamid + TX, pyrimethanil + TX, benzyl methamidophos + TX, butyl morpholine + TXFenpyrad + TX, Amifenozide + TX, Azoxystrobin + TX, Acaricide + TX, Fenoxam + TX, Fenthion + TX, Ethyl Fenthion + TX, Triphenyltin + TX, Fentrifanil + TX, Ferrous Ferb + TX, Ferimzone + TX, Ferric Phosphate + TX, Fludioxonil + TX, Pyridaben + TX, Fluazinam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flucofuron + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam + TX, Flufenoxam metylsulforim + TX, flumorpholine + TX, fluopicolide + TX, flufenoxuron + TX, fluopicolide + TX, flufenoxuron + TX, flufenoxuron + TX, fluoxapiprolin + TX, fluoxazin + TX, fluoxytioconazole + TX, fluoxazin + TX, fluoxazin hydrochloride + TX, fluquinazole + TX, flusilazole + TX, flusulfamide + TX, fluthiazolinone + TX, flutolanil + TX, fenazate + TX, fluopicolide + TX, FMC 1137+TX, Captan+TX, Formaldehyde+TX, Amitraz+TX, Amitraz Hydrochloride+TX, Formparanate+TX, Fosetyl-Aluminium+TX, Butylthion+TX, Phosphate-Arsenate+TX, Fosthietan+TX, Frontalin+TX, Wheat-Spinning Agent+TX, Furalaxyl+TX, Furazolidone+TX, Furazolidone+TX, Pyrethrum+TX Furfural + TX, γ-HCH + TX, chlorophenanthrene + TX, Grandlure + TX, Grandlure I + TX, Grandlure II + TX, Grandlure III + TX, Grandlure IV + TX, Biguanide Octyl Salt + TX, Biguanide Octyl Acetate + TX, Benzylfentanyl + TX, HCH + TX, Hemel + TX, Hempa + TX, HEOD + TX, Heptachlor + TX, Phosphate + TX, Heterorhabditis bacteriophora and H. megidis + TX, Hexaconazole + TX, Cetylcyclopropane Carboxylate + TX, Hexalure + TX, Hexamide + TX, HHDN + TXHippodamia convergens + TX, Mercaptan + TX, Quicklime + TX, Hydrogen cyanide + TX, Hymexazol + TX, Quinoline + TX, Imanin + TX, Imazalil + TX, Imidazole + TX, Biguanidine + TX, Indexpyram + TX, Smecta + TX, Ipfentrifluconazole + TX, Ipflufenoquin + TX, Isoprothiolane + TX, Iprodione + TX, Propineb + ​​TX, Ipsdienol + TX, Ipssenol + TX, IPSP + TX, Isamidophos + TX, Chlorpyrifos + TX, Carbohydrate + TX Methamidophos + TX, Isoril + TX, Isofenphos + TX, Iprodione + TX, Iprodione + TX, Transplanting agent + TX, Isoprothiolane + TX, Pyraclostrobin + TX, Isopyraclostrobin + TX, Oxadiazon + TX, Japonilure sex pheromone + TX, Jasminyl ester I + TX, Jasminyl ester II + TX, Iodine + TX, Juvenile hormone I + TX, Juvenile hormone II + TX, Juvenile hormone III + TX, Thiamethoxam + TX, Kasugamycin + TX, Kasugamycin hydrochloride hydrate + TX, Chloramphenicol + TX, Kinetin + TX, Acetylpyridinium + TX, Azoxystrobin + TX, Lead arsenate + TX, Leptomastix parasitic wasp dactylopii+TX, bromophenylphosphine+TX, lindane+TX, trimethyldioxane-nonane (lineatin)+TX, acetamiprid+TX, litlure+TX, looplure+TX, lvbenmixianan+TX, thiamethoxam+TX, macrorolophus caliginosus+TX, magnesium phosphide+TX, propiconazole+TX, cabbage looper NPV+TX, mancozeb+TX, mancozeb+TX, mandestrobin+TX, mandipropamid+TX, mancozeb+TX, azidophos+TX, m-isopropylphenyl methyl carbamate+TX, phosmet+TX, mecarphon+TX, medlure+TX, chlorfluazuron+TX, megatomoic acid acid)+TX, phosmet+TX, pyraclostrobin+TX, cyhalothrin+TX, dithiamethoxam+TX, methamidophos+TX, mercuric oxide+TX, mercurous chloride+TX, methifenazole+TX, methyl sulfoxide+TX, metalaxyl+TX, methamidophos potassium salt+TX, methamidophos sodium salt+TXMetaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. acridum anisopliae var. anisopliae) + TX, metarylpicoxamid + TX, tebuconazole + TX, metepa + TX, chlorfenapyr + TX, methyl sulfonyl fluoride + TX, methasulfocarb + TX, methiotepa + TX, methoxyfenozide + TX, methoxyfenozide + TX, methoxyfenozide + TX, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester + TX, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (these compounds can be derived from WO The method described in 2020 / 193387 is used to prepare methyl 2-propanoate (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoate + TX, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate + TX, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy] Methyl propionate + TX, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]-propionate (these compounds can be prepared by the method described in WO2020 / 079111) + TX, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propionate + TX, methyl methoxyphosphazene (methyl Methyl isothiocyanate + TX, methyl bromide + TX, methyleugenol + TX, methyl isothiocyanate + TX, N-[[4-[1-(2,6-difluoro-4-isopropyl-phenyl)pyrazol-4-yl]-2-methyl-phenyl]methyl]carbamate (which can be prepared by the method described in WO 2020 / 097012) + TX, N-[[4-[1-(4-cyclopropyl-2,6-difluoro-phenyl)pyrazol-4-yl]-2-methyl-phenyl]methyl]carbamate (which can be prepared by the method described in WO 2020 / 097012) + TX, N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamate + TX, methyl chloroform + TX, dichloromethane + TX,methylneodecanamide + TX, mancozeb + TX, cypermethrin + TX, phenoxyacetic acid + TX, oxadixyl + TX, benomyl + TX, metyltetraprole + TX, MGK 264 + TX, milbemazole + TX, propanil + TX, methamidophos + TX, phosmet + TX, morzid + TX, moxifloxacin + TX, muscalure + TX, cyproconazole + TX, myclozoline + TX, *Lysimachia christinae* composition + TX, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds can be derived from WO4) Prepared by the method described in 2017 / 153380) + TX, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds can be prepared by WO The method described in 2017 / 153380 is used to prepare N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidin + TX, N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidin + TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide + TX, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine (these compounds can be prepared by WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO The method described in 2017 / 118689 is used to prepare TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1R ...R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[( Amine + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX,N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide + TX, N-[2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium (this compound can be derived from WO4) The method described in 2016 / 202742 is used to prepare TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidin + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidin + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl)-N-isopropyl-N-methyl-formamidin (these compounds can be prepared by WO Prepared by the method described in 2015 / 155075) + TX, N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methylformamidin (this compound can be prepared by the method described in IPCOM000249876D) + TX, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methylformamidin + TX, N'-[5- Bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidin + TX, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidin + TX, N-[N-methoxy-C-methyl-carbonimide]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (these compounds can be derived from WO4) The following compounds can be prepared by the method described in WO 2018 / 202428: N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidin (these compounds can be prepared by the method described in WO 2018 / 228896)+TX, sodium mancozeb+TX, naphthylphosphide+TX, dibromophos+TX, naphthalene+TX, NC-170+TX, Neodiprionsertifer NPV and N. lecontei NPV+TX, nerolidol+TX,N-Ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide + TX, N-Ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl]oxetane-2-yl]phenyl]-N-methylformamidin + TX, bis(dimethyldithiocarbamate)nickel + TX, nicotine + TX, nicotine sulfate + TX, flufenoxuron + TX, nicotinic acid + TX, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)] [Phenylene]-N-methylformamidin + TX, nitrazepam + TX, trichloromethylpyridine + TX, pendicarb + TX, pendicarb 1:1 zinc chloride complex + TX, phthalimide + TX, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide + TX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenylthioamide + TX, cyproterone + TX, fluorophenylpyrimidinol + TX, O,O, O',O'-tetrapropyl dithiophosphate + TX, octadec-2,13-dien-1-yl acetate + TX, octadec-3,13-dien-1-yl acetate + TX, octathiazone + TX, furfuramide + TX, oleic acid + TX, omethoate + TX, orfralure + TX, *Orfrostella* species + TX, oryctalure aggregation pheromone + TX, oxadiazon + TX, ostramone + TX, oxadixyl + TX, oxamate + TX, oxat hiapiprolin + TX, quinoline copper + TX, oxoridic acid + TX, oxychloride + TX, sulfadiazine + TX, sulfadiazine + TX, oxytetracycline + TX, paclobutrazol + TX, *Paecilomyces roximate* + TX, p-dichlorobenzene + TX, parathion + TX, methyl parathion + TX, isoprothiolane + TX, tebuconazole + TX, pencycuron + TX, fluopyram + TX, penfluron + TX, penchlorophenol + TX, pentachlorophenyl laurate + TX, penthiophanate + TX, penthiophanate + TX, permethrin + TX, pH 60-38+TX, Cyazofamid+TX, Fenthion+TX, Ratphos+TX, Phosphate+TX, Chlorpyrifos+TX, Thiophanate+TX, Glyphosate+TX, Parachlorfon+TX, Phosphamidon+TX, Phosphine+TX, Phosphine+TX, Methyl phoxim+TX, Phenylphthalide+TX, Phytoseiulus persimilis+TX,Piperazine + TX, picarbutrazox + TX, azoxystrobin + TX, rotamethrin + TX, piperazine + TX, piperonyl butyl ether + TX, synergistic aldehyde + TX, methamidophos + TX, polychlorinated dicyclopentadiene isomer + TX, polychloroterpenes + TX, polynactins + TX, polyoxins + TX, potassium arsenite + TX, potassium ethyl xanthate + TX, potassium hydroxyquinoline sulfate + TX, potassium thiocyanate + TX, pp'-DDT + TX, precocious peptone I + TX, precocious peptone II + TX, precocious peptone III + TX, pyrimidin + TX, thiabendazole + TX, imidacloprid Fresh amine + TX, Prochloraz + TX, Procymidone + TX, Cypermethrin + TX, Iprodione + TX, Mancozeb + TX, Propiconazole + TX, Zineb + ​​TX, Procymidone + TX, Proquinazid + TX, Ethiazophos + TX, Prothioconazole + TX, Prothioconazole + TX, Frythiophanate + TX, Fluopyram + TX, Azoxystrobin + TX, Azoxystrobin + TX, Azoxystrobin + TX, Pyrapropoyne + TX, Pyraziflumid + TX, Pyraphos + TX, Pyrethrum + TX TX, Pyrethroid I+TX, Pyrethroid II+TX, Pyrethroid +TX, Iridachlometyl +TX, Pyridachlometyl +TX, Pyridine-4-amine +TX, Pyrifenox +TX, Pyrimethanil +TX, Pyrimethanil +TX, Pyrmethanil +TX, Pyrmorpholine +TX, Warfarin +TX, Pyriofenone +TX, Pyridaben +TX, Pyroquilon +TX, Quassia +TX, Quinalphos +TX, Quinalphos-methyl +TX, Quinoclamine +TX Quinofumelin + TX, Quinonamid + TX, Phosphatidylcholine + TX, Quinoxaline + TX, Quintiofos + TX, Pentachloronitrobenzene + TX, R-1492 + TX, Iodosylamine + TX, Cypermethrin + TX, Polygonum cuspidatum extract + TX, Ribavirin + TX, R-Methamphetamine + TX, Rotenone + TX, Rheinidine + TX, S421 + TX, Sabadilla + TX, Octylphosphamide + TX, Allium glycoside + TX, Cymoxanil + TX, Sebufos + TX, Sedaxane + TX, Slaketine + TX, Synergistic Powder + TXSesasmolin + TX, SI-0009 + TX, Siglure + TX, Simazine + TX, Simeconazole + TX, Sodium Arsenite + TX, Sodium Cyanide + TX, Sodium Fluoride + TX, Sodium Fluoroacetate + TX, Sodium Hexafluorosilicate + TX, Sodium Pentachlorophenolate + TX, Sodium Selenate + TX, Sodium Tetrathiocarbonate + TX, Sodium Thiocyanate + TX, Threshion + TX, Sordidin + TX, Spirocyclohexane + TX, SSI-121 + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis+TX, Steinernema scapterisci+TX, and species of the genus Steinernema spp.)+TX, streptomycin+TX, streptomycin sesquisulfate+TX, strychnine+TX, sulcatol+TX, sulcofuron+TX, sulcofuron-sodium+TX, sulfamethoxam+TX, fipronil+TX, thiotetracycline+TX, sulfoxide+TX, sulfur+TX, thiodimethyl fluoride+TX, thiopropionate+TX, tar+TX, t-flufenoxam+TX, tazimcarb+TX, TDE+TX, tebuconazole+TX, isobutylethoxyquinoline+TX, butylpyrimidine phosphate+TX, phosmet+TX, dithionine+TX, tepa+TX, TEPP+TX, cyclopentylpyrethrin+TX, terbam+TX, N-[6-[[[(1-methyltetrazol-5-yl)- [Phenylene-methylene]amino]oxymethyl]-2-pyridyl]tert-butyl carbamate +TX, tetrachloroethane +TX, tetrachlorothiophene +TX, flufenoxuron +TX, tetradec-11-en-1-ylacetate +TX, tetrachlorfon +TX, tetrafluoromethrin +TX, acaricide +TX, thallium sulfate +TX, thibendazole +TX, thiafenoxuron +TX, thiapronitrile +TX, thiamethoxam +TX, thiamethoxam +TX, thiamethoxam +TX, oxadixyl +TX, thiamethoxam oxalate +TX, thiamethoxam +TX, thiohempa +TX, thimerosal +TX, methyl phorate +TX, chlorpyrifos +TX, methyl thiophanate +TX, chlorpyrifos +TX, chlorpyrifos +TX, thiamethoxam +TX, chlorpyrifos +TX, chlorpyrifos sodium +TX, thiophanate +TX, thiophanate +TX, thiamethoxam +TX, silyl oxadixyl +TX, thiamethoxam +TXThiamethoxam + TX, methyl thiophanate + TX, tolprocarb + TX, parathion + TX, tetrabromopyr + TX, transchlorpyrifos + TX, tratamidophos + TX, triadimefon + TX, triadimefon + TX, phosmet + TX, bensulfuron + TX, azoxystrobin + TX, triazophos + TX, triazolamide + TX, triazol + TX, tributyltin oxide + TX, trichlormetaphos-3 + TX, phosphamidon + TX, Trichogrammae + TX, chlorpyrifos + TX, tricyclazole + TX, tridemorph + TX, snail Trifenmorph + TX, Trichloropropoxyfen + TX, Azoxystrobin + TX, Fluopyram + TX, Azoxystrobin + TX, Trimedlure + TX, Mediterranean fruit fly attractant A + TX, Mediterranean fruit fly attractant B1 + TX, Mediterranean fruit fly attractant B2 + TX, Mediterranean fruit fly attractant C + TX, Trimethocarb + TX, Trimethoprim + TX, Anti-rot ester + TX, Triphenyltin acetate + TX, Triphenyltin hydroxide + TX, Tebufenozide + TX, Mefenoxam + TX, Trunc-call + TX, Typhlodromus occidentalis)+TX, urethaneimine+TX, effectivemycin+TX, valafenamide+TX, aphidicide+TX, vaniliprole+TX, veratrine+TX, veratrine+TX, synergistic alkyne+TX, Verticillium lecanii+TX, vinclozoline+TX, rodenticide+TX, XMC+TX, xylenol+TX, zeatin+TX, zetamethrin+TX, kasugamycin+TX, zinc naphthenate+TX, zinc phosphide+TX, zinc thiamethoxam+TX, zineb+TX, thiram+TX, chlorpyrifos+TX;

[0317] Acinetobacter rumeni + TX, Cladosporium + TX, Cephalosporium + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Cotton brown belt moth granulovirus (AdoxGV) +TX, Agrobacterium radioactive strain K84 +TX, Alternaria +TX, Alternaria cassia +TX, Alternaria destruens (damaged Alternaria) +TX, powdery parasitic spores +TX, Aspergillus AF36 +TX, Aspergillus flavus NRRL 21882 +TX, Aspergillus species +TX, Budding short-branch molds +TX, Azotospira ( TAZO +TX, nitrogen-fixing bacteria +TX, Azotobacter chroocuccum +TX, Bionatural Blooming Bacillus amyloliquefaciens +TX, Bacillus cereus +TX, Bacillus chitinosporus strain AQ746 +TX, Bacillus chitinosporus strain CM-1 +TX, Bacillus circulans +TX, Bacillus sturdier In particular, strain CNMC 1-1582 (e.g., from BASF AG) )+TX, Bacillus licheniformis strain 3086 ( Green )+TX, Bacillus licheniformis strain HB-2 (Biostart TM Originally called )+TX, Bacillus marismortui+TX, Bacillus megaterium+TX, Bacillus mycosis fungoides strain AQ726+TX, Bacillus lactis (Milky Spore) )+TX, Bacillus subtilis species+TX, Bacillus subtilis strain AQ717+TX, Bacillus subtilis strain GB34 (Yield) )+TX, Bacillus pumilus strain QST 2808 ( Ballad )+TX, Bacillus spheroidae +TX, Bacillus species +TX, Bacillus strain AQ175+TX, Bacillus strain AQ177+TX, Bacillus strain AQ178+TX, Bacillus subtilis strain AQ153+TX, Bacillus subtilis strain AQ743+TX, Bacillus subtilis strain QST 713 +TX, Bacillus subtilis strain QST 714 +TX, Bacillus subtilis strain QST3002+TX, Bacillus subtilis strain QST3004+TX, Bacillus subtilis variant strain FZB24 +TX, Bacillus thuringiensis aizawai GC 91 +TX, Bacillus thuringiensis Cry2Ae+TX, Bacillus thuringiensis Cry1Ab+TX, Bacillus thuringiensis israelensis +TX, Bacillus thuringiensis kurstaki ( Scutella Turilav Dipel +TX, Bacillus thuringiensis Kurstak BMP 123 +TX, Bacillus thuringiensis Kurstak HD-1 (Bioprotec-CAF / Bacillus thuringiensis tenebrionis (+TX, Bacillus thuringiensis strain AQ52+TX, Bacillus thuringiensis strain BD#32+TX, Bacillus thuringiensis tenebrionis)

[0318] BtBooster+TX, Bacillus thuringiensis var. aizawai +TX, Bacteria spp. +TX, Clavipactermichiganensis bacteriophage +TX, Beauveria bassiana (Beauveria bassiana) Brocaril )+TX, Beauveria bassiana GHA (Mycotrol) Mycotrol )+TX, Beauveria brongniartii ( Schweizer )+TX, Beauveria spp. species+TX, Botrytis cineria+TX, Bradyrhizobium japonicum slow-growing rhizobium of soybean +TX, Brevibacillus brevis +TX, Burkholderia cepacia ( Blue Burkholderia gladii +TX, Burkholderia gladioli +TX, Burkholderia spp. +TX, Canadian thistle fungus (CBH Canadian) Candida butyri +TX, Candida famata +TX, Candida fructus +TX, Candida glabrata +TX, Candida guilliermondii +TX, Candida melibiosica +TX, Candida oleophila strain O +TX, Candida parapsilosis +TX, Candida pelliculosa +TX, Candida pulcherrima +TX, Candida reukaufii +TX, Candida saitoana +TX, Candida sake +TX, Candida spp. +TX, Candida tenius +TX, Cediclofenac +TX, Cellulomonas flavigena +TX, Chaetomium cochliodes +TX, Chaetomium globosum +TX, Chromobacterium subtsugae strain PRAA4-1T +TX, Cladosporium chlorocephalum +TX, Cladosporium cladosporioides +TX, Cladosporium oxysporum +TX, Cladosporium spp. +TX, Cladosporium tenuissimum +TX, Clonastachys rosea +TX, Colletotrichum acutatum +TX, Coniothyrium minitans (Cotans )+TX, Coniothyrium spp.+TX, Cryptococcus albidus +TX, Cryptococcus humicola +TX, Cryptococcus infirmo-miniatus +TX, Cryptococcus laurentii +TX, Cryptoophlebia leucotreta granulovirus +TX, Cupriavidus campinensis+TX, Cydia pomonella granulovirus (Cydia pomonella granulovirus)

[0319] Plus, Madex Max +TX, Cylindrobasidium laeve +TX, Cylindrocladium +TX, Debaryomyces hansenii +TX, Drechslera hawaiinensis +TX, Enterobacter cloacae +TX, Enterobacteriaceae +TX, Entomophthora virulenta +TX, Epicoccum nigrum +TX, Epicoccum purpurascens +TX, Epicoccum species +TX, Filobasidium floriforme +TX, Fusarium argentis +TX, Fusarium chlamydosporium +TX, Fusarium oxysporum ( Biofox )+TX, Fusarium moniliformes+TX, Fusarium species+TX, Galactomyces geotrichum+TX, Gliocladium catenulatum +TX, Gliocladium roseum +TX, species of the genus Gliocladium +TX, Green broom mold +TX, Particulate Virus +TX, Halobacillus halophilus +TX, Halobacillus litoralis +TX, Halobacillus trueperi +TX, species of Halomonas +TX, Halomonas subglacialis +TX, Halovibriovariabilis +TX, Hansenula polymorpha in grape juice +TX, cotton bollworm nucleopolyhedrovirus +TX, Grainworm nucleopolyhedrovirus +TX, *Cladosporium rosenbergii* (formerly known as *Paecilomyces rosenbergii* strain) )+TX, isoflavones and gentianin +TX, Klebsiella lemonis +TX, Klebsiella species +TX, Lagenidium giganteum +TX, *Lecanicillium lecanii* (formerly known as strain KV01, e.g., Koppert / Arysta) Verticillium lecanii Conidia + TX, Lecanicillium longisporum +TX, Lecanicillium muscarium +TX, Gypsy moth nucleopolyhedrovirus +TX, Halophilic sea cocci +TX, Meira geulakonigii +TX, Destruxin )+TX, Metarhizium anisopliae +TX、Metschnikowia fruticola +TX, Metschnikowia pulcherrima+TX, Microdochium dimerum +TX, Micromonospora coerulea (sky blue) +TX, Microsphaeropsis ochracea +TX, Muscodor albus (foul-smelling white fungus) 620 +TX, *Muscodor roseus*, especially strain A3-5 (registration number NRRL 30548) +TX, mycorrhizal species (*Mycorrhizae* spp.). Root )+TX, *Varicocele variegata* strain AARC-0255 ( BROS )+TX, Ophiostoma piliferum strain D97 +TX, Paecilomyces farinosus +TX, Paecilomyces lilacinus strain 251 (MeloCon )+TX, Paecilomyces lilacinus (Biostat) )+TX, Bacillus polymyxa +TX, BlightBan +TX, Pantotheca species +TX, Pasteuria nishizawae, especially strain Pn1 (from Syngenta / ChemChina's CLARIVA); +TX, Bacillus species +TX, Penicillium globosum +TX, Penicillium billai +TX, Short Dense Penicillium +TX, Commonly Present Penicillium +TX, Grayish Yellow Penicillium +TX, Purple-producing Penicillium +TX, Penicillium species +TX, Pure Green Penicillium +TX, Phlebiopsis gigantean +TX, Phosphate-solubilizing bacteria +TX, Phytophthora cryptica +TX, Phytophthora palmatum +TX, Pichia aberrant +TX, Pichia guillermondii +TX, Pichia membranaceus +TX, Pichia nail +TX, Pichia trunk +TX, Pseudomonas aeruginosa +TX, Pseudomonas aureofasciens (Spot-Less) )+TX, Pseudomonas cepacia +TX, Pseudomonas aeruginosa +TX, Pseudomonas corrugate +TX, Pseudomonas fluorescens +TX, BlightBan Pseudomonas strain A506 )+TX, *Pseudomonas reactans*+TX, *Pseudomonas* species+TX, *Pseudomonas syringae* +TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex )+TX, Puccinia canaliculata+TX, Puccinia thlaspeos (Wood) )+TX, Pythium oligandrum+TX, Oligandrum +TX, *Pythium spp.* +TX, *Rhanella aquatilis* +TX, *Rhanella spp.* +TX, *Rhizobium* +TX, Rhizoctonia +TX, Rhodococcus globerulus strain AQ719 +TX, Rhodosporidium diobovatum +TX, Rhodosporidium toruloides +TX, Rhodotorula glutinis +TX, Rhodotorula graminis +TX, Rhodotorula mucilagnosa +TX, Rhodotorula rubra +TX, Rhodotorula spp. +TX, Saccharomyces cerevisiae +TX, Salinococcus roseus +TX, Sclerotium spp. +TX, Sclerotium sclerotiorum +TX, Scytalidium spp. +TX, Scytalidium uredinicola +TX, Serratia marcescens +TX, Serratia plymuthica +TX, Serratia spp. +TX, Sordaria fimicola +TX, Beet armyworm nucleopolyhedrovirus +TX, Spodoptera littoralis nucleopolyhedrovirus (Sea Grey-winged Noctuid Moth) +TX, *Sporobolomyces roseus* +TX, *Stenotrophomonas maltophilia* +TX, *Streptomyces albaduncus* +TX, *Streptomyces exfoliates* +TX, *Streptomyces galbus* +TX, *Streptomyces griseoplanus* +TX, *Streptomyces griseoviridis* +TX, Streptomyces hygroscopicus +TX, Streptomyces lydicus +TX, Streptomyces lidiflora WYEC-108 +TX, Streptomyces violaceus +TX, Tilletiopsis minor +TX, Tilletiopsis spp. +TX, Trichoderma asperellum (T34) +TX, Trichoderma atroviride +TX, Trichodermagamsii +TX, Trichoderma hamatum TH 382+TX, Trichoderma harzianum rifai +TX, Trichoderma harzianum T-22 ( PlantShield )+TX, Trichoderma harzianum T-39 +TX, Trichoderma inhamatum +TX, Trichoderma koningii +TX, Trichoderma lignorum +TX, Trichoderma longibrachiatum +TX, Trichoderma polysporum (Binab) )+TX, Trichoderma species (Trichoderma spp.) LC 52 +TX, Trichoderma taxi, +TX, Trichoderma viride (formerly known as green broom mold GL-21) +TX, Trichoderma virens +TX, Trichoderma viride +TX, Trichoderma viride strain ICC 080 +TX, *Trichosporon pullulans* +TX, *Trichosporon* spp. +TX, *Trichothecium roseum* +TX, *Trichothecium* spp. +TX, *Typhula phacorrhiza* strain 94670 +TX, *Typhula phacorrhiza* strain 94671 +TX, *Ulocladium atrum* +TX, *Ulocladium oudemansii* +TX, Ustilago maydis (corn smut), various bacteria and supplements (Natural) )+TX, various fungi (Millennium) )+TX, Verticillium chlamydosporium+TX, Vip3Aa20 +TX, Virgibaclillus marismortui +TX, Xanthomonas praecox pv. Poae +TX, Burkholderia bronchiseptica +TX, Nematophyte pathogens +TX;

[0320] MMF+TX, Plasma Neem For example, AZATINXL+TX from Certis, USA, and plant-based IGR +TX、 +TX, Lilly Miller canola oil )+TX, Chenopodium ambrosioides near ambrosioides +TX, chrysanthemum extract +TX, Labiatae essential oil +TX, Neem oil extract +TX, clove-rosemary-peppermint and thyme oil extracts (Gardeninsect) )+TX, garlic+TX, betaine +TX, Kaolin +TX, lemongrass oil +TX, Tea Tree Oil Extract (also known as Tea Tree Oil) (Timorex) )+TX, clove-peppermint-garlic oil and mint blend (Soil) )+TX, a blend of clove-rosemary and peppermint extracts (EF) )+TX, a blend of rosemary-sesame-peppermint-thyme and cinnamon extracts (EF) Nepeta cataria (catnip oil) + TX, Nepeta cataria + TX, Nicotine + TX, Oregano oil +TX, Pedaliaceae oil +TX, pine oil +TX, Pyrethrum +TX, Quillajasaponaria +TX, Reynoutria sachalinensis +TX, Rotenone (Eco )+TX, Rutaceae plant extracts +TX, soybean oil (Ortho) )+TX, storage glucan of brown algae +TX, thyme oil +TX;

[0321] (E,Z)-7,9-dodecadien-1-yl acetate + TX, (E,Z,Z)-3,8,11-tetradecanetrien acetate + TX, (Z,Z,E)-7,11,13-hexadecanetrienal + TX, 2-methyl-1-butanol + TX, +TX, Blackheaded Fireworm Pheromone (3M Sprayable Blackheaded Fireworm) )+TX, calcium acetate+TX, +TX, codling moth pheromone (Paramount dispenser-(CM) / Isomate) )+TX, Entostat powder (an extract from palm trees) (Exosex) )+TX, Grape Leafroller Pheromones (3M MEC-GBM Sprayable) )+TX, Lavandulylsenecioate+TX, Leafroller Pheromone (3M MEC-LR Sprayable) +TX, housefly pheromone (Muscamone) (Snip7 Fly) +TX, Pear fruit moth pheromone (3Morientalfruit moth sprayable) +TX, Peachtree Borer pheromone +TX、 +TX, Starbar Premium Fly )+TX, Tomato Pinworm pheromone (3M Sprayable) )+TX;

[0322] Acerophagus papaya+TX, Ladybug +TX, Ladybug +TX, Ladybug +TX, Agniaspis citricola +TX, Amblyseius andersoni (multiembryonic wasp) +TX +TX, Amblyseius californicus +TX, Cucumber amblyseius ( Bugline )+TX, Pseudo-Amblyseius +TX, Amblyseius swirskii (Bugline) )+TX, Amblyseius ostei +TX, Whitefly Wasp (Amitus hesperidum) +TX, Cherry-winged Wasp (Anagrus atomus) +TX, Dark-bellied Long-corded Wasp (Anagyrus fusciventris) +TX, Kama Long-corded Wasp (Anagyrus kamali) +TX, Anagyrus loecki +TX, Scale Insect Long-corded Wasp (Anagyrus pseudococci) +TX, Red Wax Scale (Anicetus benefices) +TX, Golden Wasp (Anisopteromalus calandrae) +TX, Woodland Flower Bug (Anthocoris nemoralis) +TX, Short-spurred Aphid Wasp +TX, Aphelinus asychis (a short-winged aphid wasp) +TX, Aphidius colemani (a cotton aphid parasitic wasp) +TX, Aphidius ervi +TX, Alpha aphid wasp +TX, Tobacco Aphid Parasitoides +TX, Peach Red Aphid Parasitoides +TX, Aphid-eating gall midge +TX, Lingnan Yellow Aphid Wasp +TX, Indian and Pakistani Yellow Aphid Wasp +TX, Aprostocetus hagenowii +TX, Atheta coriaria +TX, species of the genus Bumblebee +TX, European Bumblebee +TX, European bumblebee (Natupol) )+TX, Cephalonomia stephanoderis+TX, Black-backed Ladybug (Chilocorus nigritus+TX), Common Lacewing (Chrysoperlacarnea) +TX, Red Lacewing (Chrysoperla rufilabris) +TX, Cirrospilus ingenuus +TX, Four-banded Chrysalis Wasp (Cirrospilus quadristriatus) +TX, White-spotted Orange Wasp (Citrostichus phyllocnistoides) +TX, Closterocerus chamaeleon +TX, Species of the genus Closterocerus +TX, Coccidoxenoides perminutus +TX, Coccophagus cowperi +TX, Coccophagus lycimnia +TX, Coccophagus cyprini +TX, Coccophagus cyprini +TX, Coccophagus cyprini +TX, Coccophagus monnieri +TX, Japanese square-headed beetle +TX, Siberian mandibular wasp +TX, Ladybug (Delphastus catalinae) +TX, Delphastus pusillus+TX, Diachasmimorpha krausii+TX, Long-tailed leafminer wasp+TX, Diaparsis jucunda+TX, Ali lice-eating wasp (Diaphorencyrtus aligarhensis+TX), Pea leafminer wasp +TX, species of the genus *Ceratophorus* +TX, *Ceratophorus spp.* +TX, *Encarsia* )+TX, Encarsia guadeloupae+TX, Encarsia haitiensis+TX, and the fine-toothed hoverfly +TX, Eretmoceris siphonini+TX, California horn wasp (Eretmocerus californicus+TX, California horn wasp (Eretmocerus eremicus))( Eretline )+TX, Hesperidium humilis wasp+TX, Montgomery's humilis wasp ( Eretline )+TX, Eretmocerus siphonini+TX, Four-spotted Ladybug (Exochomus quadripustulatus+TX), Eating Gall midge (Feltiella acarisuga) +TX, Emacaryrhea eel +TX, Alishan leafminer wasp +TX, Fopius ceratitivorus +TX, Wirless )+TX、Slim-waisted thrips +TX, Galendromus occidentalis +TX, Goniozus legneri +TX, Brachymys moth +TX, Heteromorpha japonica +TX, NemaShield )+TX, Heterorhabditis megidis (Nemasys) BioNem Exhibitline )+TX, species of the genus Lawn +TX, Hippodamia convergens +TX, Hypoaspis aculeifer +TX, Hypoaspis miles (Hypoline) )+TX, Black Gall Beetle +TX, Lecanoideus floccissimus+TX, Lemophagus errabundus+TX, Tricolor Jumping Wasp (Leptomastidea abnormis)+TX, Orange Scale Parasitic Wasp (Leptomastix dactylopii) +TX, Leptomastix epona +TX, Lindorus lophanthae +TX, Lipolexis oregmae +TX, Forked Leaf Green Fly +TX, tea-footed aphid wasp +TX, mirid bug (Macrolophus caliginosus) Macroline )+TX, Mesoseiulus longipes+TX, Yellow broad-stalked jumping wasp (Metaphycus flavus)+TX, Metaphycus lounsburyi+TX, horned-veined brown lacewing +TX, Yellow Flowerwing Flying Wasp (Microterysflavus) +TX, Muscidifurax raptorellus and Spalangia cameroni +TX, Neodryinus typhlocybae+TX, Neoseido Seymite caecalii+TX, Neoseido Seymite cucumeris +TX, Neoseiulus fallacis +TX, Nesideocoris tenuis +TX, Bronze Black Fly +TX, the cunning little flower bug (Oriusinsidiosus) Oriline )+TX, hairless small flower bug (Orius laevigatus) ( Oriline +TX, Orius majusculus (Oriline) +TX, Black Flower Stink Bug +TX, Pauesia juniperorum+TX, Pediobius foveolatus+TX, Phasmarhabditis hermaphrodita +TX, Phymastichuscoffea+TX, Phytoseiulus macropilus+TX, Chilean Phytoseiulus macropilus ( Phytoline )+TX, Spotted Belly-Stinging Beneficial Bug +TX, Pseudacteon curvatus+TX, Pseudacteon obtusus+TX, Pseudacteon tricuspis+TX, Pseudaphycus maculipennis+TX, Pseudleptomastix mexicana+TX, Psyllaephagus pilosus+TX, Psyttalia concolor (complex)+TX, Quadrastichus spp.+TX, Rhyzobius lophanthae+TX, Australian ladybug+TX, Ruminadecollate+TX, Semielacher petiolatus+TX, Wheat long-tube aphid +TX, Nematacia sclerotiorum, a small leafroller nematode BioNem )+TX, Noctuidae stearothermiae ( Nemasys BioNem Exhibitline )+TX, Steinernema kraussei (Nemasys) BioNem Exhibitline )+TX, Steinernema riobrave +TX, Steinernema scapterisci (Nematac) )+TX, species of the genus *Steinernematid* +TX, species of the genus *Guardian* (family Steinernematid). )+TX, Deep-seated ladybugs +TX, *Tetrastichus setifer* +TX, *Thripobius semiluteus* +TX, *Torymussinensis* +TX, *Tricholine* +TX, Trichogramma elegans, cabbage moth +TX, Trichogramma platneri +TX, Trichogramma microscopicum +TX, Trichogramma corn borer +TX, Trichogramma platneri +TX, Trichogramma short-tubedum +TX, Xanthopimpla stemmator +TX;

[0323] abscisic acid + TX +TX、 +TX、 +TX, CAS number: 2643947-26-4+TX, Chondrostereum purpureum (Chontrol )+TX, Discoid spores +TX, Copper Octanoate +TX, Delta trap (Trapline) )+TX, Erwinia amyloliquefaciens (Harpin) Ni-HIBIT Gold )+TX, fatty acids derived from natural byproducts of extra virgin olive oil +TX, Ferric Phosphate +TX, Funneltrap (Trapline) )+TX、 +TX、Grower's +TX, Homo-brassonolide, ferric phosphate (Lilly Miller Worry Free Ferramol Slug & Snail) +TX, MCP hail trap (Trapline) )+TX, parasitic insects, Southern food beetle (Microctonus hyperodae)+TX, Mycoleptodiscus terrestris +TX, Semaspore Organic Grasshopper +TX, Thripline (Pheromone Network) )+TX, potassium bicarbonate +TX, potassium iodide + potassium thiocyanate +TX, potassium salts of fatty acids +TX, potassium silicate solution +TX, Spider Venom +TX, Trapline Rebell )+TX、 +TX, Takitrapline )+TX;

[0324] Mojave Bacillus strain R3B (accession number NCAIM(P)B001389)(WO2013 / 034938)+TX from Certis USA, a small spore-forming bacterium, particularly strain BU F-33, with NRRL accession number 50185 (from BASF). EPA registration number 71840-19)+TX, from Certis USA, Bacillus subtilis CX-9060, Bacillus species, specifically strain D747 (from Kumiai Chemical Industry Co., Ltd., DOUBLE). Available), with registration number FERM BP-8234, US Patent No. 7,094,592+TX, Bacillus subtilis strain BU1814, (from BASF AG) PLUS FLEX and EXTRA)+TX, Bacillus subtilis variant strain FZB24, with accession number DSM 10271 (from Novozymes). or ECO can obtain (EPA registration number 70127-5)+TX, Bacillus subtilis, especially strain QST713 / AQ713 (with NRRL registration number B-21661 and described in US patent number 6,060,051, from Bayer CropScience LP, USA). OPTI or ASO is available) +TX, Bacillus polymyxa, especially strain AC-1 (e.g., from Green Biotech Company Ltd.) )+TX, a strain of the genus Bacillus, with accession number NRRL B-50972 or NRRL B-67129, WO 2016 / 154297+TX, clustered pan-wine bacteria, especially strain E325 (accession number NRRL B-21856) (from Northwest Agri Products under the name BLOOMTIME BIOLOGICAL). TM FDBIOPESTICIDE (available) +TX, Pseudomonas proradix (e.g. from Sourcon Padena) )+TX;

[0325] Budding short-stemmed fungi, particularly budding spores of strain DSM14940, budding spores of strain DSM14941, or mixtures of budding spores of strains DSM14940 and DSM14941 (e.g., from the Swiss bio-ferm). and BLOSSOM )+TX, Candida antarcticis (such as the one disclosed by Yissum Research Development Company of the Hebrew University of Jerusalem in WO 2011 / 151819)+TX, Saccharomyces cerevisiae, especially strains CNCM 1-3936, CNCM 1-3937, CNCM 1-3938 or CNCM 1-3939 (WO 2010 / 086790)+TX from Lesaffre et Compagnie, France;

[0326] Agrobacterium radialis strain K84 (e.g., from AgBioChem, California) )+TX, Bacillus amyloliquefaciens isolate B246 (e.g., from AVOGREEN, University of Pretoria)TM )+TX, Bacillus amyloliquefaciens strain F727 (also known as strain MBI110) (NRRL registry number B-50768, WO 2014 / 028521) (from Marrone BioInnovations) )+TX, Bacillus amyloliquefaciens strain FZB42, registry number DSM 23117 (from ABiTEP GmbH, Germany) Available) +TX, Bacillus amyloliquefaciens, especially strain D747 (from Combinatorial Chemicals Industries, using Double Nickel) TM Available, with registration number FERM BP-8234, US Patent No. 7,094,592)+TX, Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (from FMC Corporation) (WG) and (WP))+TX, Bacillus licheniformis, particularly strain SB3086, with accession number ATCC 55406, WO 2003 / 000051 (from Novozymes). Biological fungicide and Green Releaf TM Available) +TX, Bacillus methylotrophicus strain BAC-9912 (from the Chinese Academy of Sciences' Institute of Applied Ecology) +TX, Bacillus mycosiscinus, isolate, with accession number B-30890 (from Certis, USA, under BMJ) Or WG and LifeGard TM Available) +TX, Bacillus pumilus, especially strain GB34 (from Bayer AG, Germany, under the Yield) Available)+TX, Bacillus pumilus, especially strain QST2808 (from Bayer Crop Science, USA) Available, with registration number NRRL B-30087 and described in U.S. Patent No. 6,245,551)+TX, Bacillus subtilis CX-9060+TX from Certis USA, and Bacillus subtilis IAB / BS03 (from STK Bio-Ag Technologies AVIV) TM From Idai Nature )+TX, Bacillus subtilis KTSB strain (from Donaghys) )+TX, Bacillus subtilis strain BU1814, (from BASF AG) PLUS FLEX and EXTRA available) +TX, Bacillus subtilis strain GB03 (from Bayer AG, Germany) Available) +TX, Bacillus subtilis strain MBI 600 (available from BASF AG via SUBTILEX), with registration number NRRL B-50595, US patent number 5,061,495 +TX, Bacillus subtilis strain Y1336 (available from Bion-Tech, Taiwan) WP is available as a biofungicide registered in Taiwan, under registration numbers 4764, 5454, 5096, and 5277 (+TX), and is a variant of Bacillus subtilis strain FZB24 with registration number DSM 10271 (obtained from Novozymes). or ECO can obtain (EPA registration number 70127-5) + TX, Bacillus subtilis Y1336 (from Taiwan Biotech Co., Ltd.) WP is available as a biofungicide registered in Taiwan under registration numbers 4764, 5454, 5096, and 5277+TX, including *Bacillus epiphyticus* (WO2016 / 020371)+TX from BASF, *Bacillus polymyxa* plant species (WO 2016 / 020371)+TX from BASF, *Bacillus* species strains with registration numbers NRRL B-50972 or NRRL B-67129, WO 2016 / 154297+TX, and *Pseudomonas aeruginosa* strain AFS009 with registration numbers NRRL B-50897, WO 2017 / 019448 (e.g., HOWLER from AgBiome Innovations). TM and )+TX, *Pseudomonas aeruginosa*, especially strain MA342 (e.g., from Bioagri and Koppert). and )+TX, Fluorescent Pseudomonas strain A506 (e.g., from NuFarm) A506)+TX, Pseudomonas proradix (e.g., from Sourcon Padena) )+TX, Streptomyces glaucusiformis strain K61 (also known as Streptomyces flavus strain K61) (accession number DSM 7206) (from Verdera) From BioWorks See Crop Protection 2006, 25, 468-475)+TX, Streptomyces lydii strain WYEC108 (also known as Streptomyces lydii strain WYCD108US) (from Novozymes' ACTINO- and )+TX;

[0327] Trichoderma viride strain T11 (IMI352941 / CECT20498)+TX, powdery mildew strain AQ10, with accession number CNCM 1-807 (e.g., AQ from IntrachemBioItalia). )+TX, powdery mildew, especially strain AQ 10 (e.g., AQ from Intertra Chemicals Italy). )+TX, Aspergillus strain NRRL 21882 (as from Syngenta / ChemChina) Known products) +TX, budding short-stemmed molds, especially budding spores of strain DSM 14941 +TX, budding short-stemmed molds, especially budding spores of strain DSM14940 +TX, budding short-stemmed molds, especially mixtures of budding spores of strains DSM14940 and DSM 14941 (e.g., from Swiss bio-ferm) )+TX, Chaetomium cupreum (registration number CABI 353812) (e.g., BIOKUPRUM from AgriLife) TM )+TX, Chaetomium globosum (from Rivale) Available)+TX, Cladosporium cladosporioides, strain H39, with accession number CBS122244, US2010 / 0291039 (by Stichting Dienst Landbouwkundig Onderzoek)+TX, scutellaria, especially strain CON / M / 91-8 (accession number DSM9660, e.g., from Bayer CropScience Biotechnology Co., Ltd.) +TX, Cryptococcus flavescens, strain 3C (NRRL Y-50378), +TX, Dactylariacandida, Dilophosphora alopecuri (as TWIST) Available), Fusarium oxysporum, strain Fo47 (from Natural Plant Protection). Available) +TX, *Streptococcus pyrenoidospora* strain J1446 (e.g., from Lallemand). )+TX, *Clonostachys rosea* strain IK726 (Jensen DF et al. Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist *Clonostachys rosea* strain 'IK726'), *Australasian Plant Pathol*. 2007, 36(2): 95-101)+TX, *Clonostachys rosea* strain ACM941, particularly strain 321U from Adjuvants Plus, such as Xue AG (Efficacy of *Clonostachys rosea* strain ACM941 and fungicide seed treatments for controlling the root tot complex of field The efficacy of *Pteris vittata* strain ACM941 and fungicide seed treatment for controlling root rot complex in field peas was disclosed in *Can Jour Plant Sci*, 2003, 83(3):519-524. Other related strains include: Metschnikowia fructicola, strain NRRL Y-30752+TX, Microsphaeropsis ochracea, *Penicillium steckii* (DSM 27859, WO 2015 / 067800)+TX from BASF, *Trichoderma gamsii* strain ICC 012 (also known as *Trichoderma harzianum* ICC012), with accession number CABICCIMI 392716, and *Trichoderma gamsii* (formerly *Trichoderma viride*) strain ICC 080, with accession number IMI. 392151 mixtures (e.g., BIO-TAM from Isagro USA, Inc.) TM Or from Agrobiosolde Mexico (SAde CV) )+TX, Penicillium vermiculatum+TX, Phlebiopsis gigantea strain VRA 1992 (from Danstar Ferment) C)+TX, Pseudozyma flocculosa, strain PF-A22 UL (from Plant Products Co., California) L (available) + TX, cell wall of Saccharomyces cerevisiae strain LAS117 (from Lesaffre) From BASF AG +TX, Saccharomyces cerevisiae strains CNCM 1-3936, CNCM 1-3937, CNCM 1-3938, CNCM 1-3939 (WO 2010 / 086790) from Lesaffre, France +TX, Saccharomyces cerevisiae, especially strain LASO2 (from Agro-Levures et Dérivés) +TX, Simplicityllium lanosoniveum +TX, strain T34 (e.g., T34 from Biocontrol Technologies SL, Spain) or strain ICC 012 from ISEG +TX, strain WRL-076 (NRRL Y-30842), US Patent No. 7,579,183 +TX, Talaromyces flavus, strain V117b +TX, Trichoderma asperelloides JM41R (registration number NRRL B-50759 (from BASF AG's TRICHO) )+TX, Trichoderma acicularis, especially strain SKT-1, with registration number FERMP-16510 (e.g. from Combinatorial Chemicals Industrial Co., Ltd.) Trichoderma echinococcus, especially strain kd (e.g., T-Gro from Andermatt Biocontrol) +TX, Trichoderma viride strain 77B (T77 from Andermatt Biocontrol) +TX, Trichoderma viride strain ATCC 20476 (IMI 206040) +TX, Trichoderma viride strain LC52 (e.g., Tenet from Agrim Technologies Limited) +TX, Trichoderma viride strain LU132 (e.g., Sentinel from Agrim Technologies Limited) +TX, Trichoderma viride strain NMI V08 / 002388 +TX, Trichoderma viride strain NMI V08 / 002389 +TX, Trichoderma viride strain NMI V08 / 002390 +TX, Trichoderma viride strain V08 / 002387 +TX, Trichoderma viride strain SKT-1 (FERM) P-16510), Japanese Patent Application (Kokai) 11-253151A+TX, Trichoderma viride strain SKT-2 (FERM P-16511), Japanese Patent Application (Kokai) 11-253151A+TX, Trichoderma viride strain SKT-3 (FERM P-17021), Japanese Patent Application (Kokai) 11-253151A+TX, Trichoderma viride, especially strain SC1 (registration number CBS122089, WO 2009 / 116106 and US Patent No. 8,431,120 (from Bi-PA)+TX), Trichoderma viride, strain CNCM 1-1237 (e.g. from Agrauxine, France). WP)+TX, Trichoderma pygmyces (e.g., TrichoPlus from BASF)+TX, Trichoderma galbsiella (formerly Trichoderma viride)+TX, Trichoderma galbsiella (formerly Trichoderma viride) strain ICC 080 (IMI CC 392151CABI) (from Agriberso Mexico) Available), +TX, Trichoderma galbense strain ICC080 (IMI CC 392151CABI, e.g., BioDerma from Agriberso Mexico), +TX, Trichoderma hookeri +TX, Trichoderma hookeri, with acces...

Claims

1. A fungicidal composition comprising components (A) and (B) as active ingredients, wherein component (A) is a compound having formula (I): Where Z is O; R 1 Selected from C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Alkyl, wherein the C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 Alkyl and C 3-6 cycloalkyl-C 1-4 Each of the alkyl groups is optionally substituted with CN; R 2a Selected from H, C 1-6 Alkyl, C 3-6 cycloalkyl and C 1-6 Alkoxy-C 1-6 alkyl; R 2b Selected from H, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 alkyl; R 2c It is H; J is N or CR 4 ; G is CR 5 ; R 3 It is H; R 4 It is halogen or CN; R 5 Selected from H, C 1-6 Alkyl, C 1-6 Alkoxy groups and halogens; A is CH or N; and R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino, C 1-6 alkoxyamino and C 1-6 Alkyl C 1-6 Alkoxyamino; Or its salts or N-oxides; and Component (B) is a compound selected from the group consisting of: acetamiprid, aramidobenzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, Bacillus amyloliquefaciens, benzovindiflubenzuron, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromuconazole, triflupyridine, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluopyram, fluoxazinamide, captan, emetolide, indoxazinamide, styraclostrobin, isofennoquine, isofennoquine Oxalide, isopyram, isothiazamide, dicytylosin, chlorfluazuron, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxetine, fluoxetine aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxetine hydroxylamine, azoxystrobin, quinoline, fluoxetine, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, trifluralin, benzoyl methoxycarb, benzoyl methoxycarb, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide [-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl [(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide.

2. The antifungal composition according to claim 1, wherein: -R 1 Selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3 and CH2CN; -R 2a Selected from H and CH3; -R 2b Selected from H, CH3, -CH2OCH3, NH2 and -NHC(O)CH3; -R 2c It is H; -J is N or CR 4 ; -G is CR 5 ; -R 3 It is H; -R 4 It is chlorine, fluorine, or CN; -R 5 Selected from H, CH3, -OCH3 and fluorine; -A is CH or N; and -R 6 Selected from cyclopropyl, -OCH3 and -NH-O-CH3.

3. The antifungal composition according to claim 1 or 2, wherein, Component (A) is selected from the following compounds: N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester, N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate, N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate, N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, Methyl N-[4-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate] 3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide, Methyl N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate Methyl N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate, N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester N-[5-[6-[(4-chloro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate, N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxy-phenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester N-[5-[6-[(4-chloro-3-methoxy-phenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, N-(4-fluoro-3-methoxy-phenyl)-3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate methyl ester Methyl N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate Methyl N-[5-[8-acetamido-6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate {N}-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate, Methyl N-[5-[6-[(2-methoxy-4-pyridinyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate, and N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate; Or its salts or N-oxides.

4. The antifungal composition according to any one of the preceding claims, wherein, The component (A) is: N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, or N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, or N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, or N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, or N-[4-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridin-3-yl]phenyl]carbamate, or 3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-a]pyridine-6-carboxamide, or {N}-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, or N-[5-[6-[(2-methoxy-4-pyridinyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate, or N-[5-[6-[(4-cyano-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridinyl]carbamate; Or its salts or N-oxides.

5. The antifungal composition according to any one of the preceding claims, wherein, The component (B) is selected from the following compounds: aramacin-s-methyl, azoxystrobin, indoxamylsulfamethoxam, pyraclostrobin, chlorothalonil, cyazofamid, triflupyridine, cymoxanil, difenoconazole, disodium phosphonate, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluoxazin, captan, dimethomorph, chlorfluazuron, metalaxyl-M, fluthiazopyrone, tetrazolium pyridaben, fluazinam, fluoxazinamide, streptomycin, benzylamidophos, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide and N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide.

6. The antifungal composition according to any one of the preceding claims, wherein, The weight ratio of component (A) to component (B) is from 100:1 to 1:

100.

7. The antifungal composition according to any one of the preceding claims, wherein, The weight ratio of component (A) to component (B) ranges from 20:1 to 1:

40.

8. The antifungal composition according to any one of the preceding claims, wherein, The weight ratio of component (A) to component (B) ranges from 12:1 to 1:

25.

9. The antifungal composition according to any one of the preceding claims, wherein, The weight ratio of component (A) to component (B) ranges from 5:1 to 1:

15.

10. The antifungal composition according to any one of the preceding claims, wherein, The weight ratio of component (A) to component (B) ranges from 2:1 to 1:

5.

11. The antifungal composition according to any one of the preceding claims, wherein, The composition further comprises an additional active ingredient component (C) different from component (B), selected from the group consisting of: acetamiprid, aramid-benzyl-S-methyl, azoxystrobin, indoxazole, pyraclostrobin, Bacillus amyloliquefaciens, benzo[a]fluoroquinolones, bromoxynil, chlorothalonil, thiamethoxam, chlorantraniliprole, cis-jasmone, bromocyanamide, trifluoperamide, cyazofamid, trifluoperamide, cymoxanil, difenoconazole, disodium phosphonate, thiamethoxam, benzylpyridinium chloride, pyridabenamide, fluazinam, fludioxonil, fluopyram, fluopyram, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, fluoxazinamide, captan, and emexopyram. Indexpyram, styraclostrobin, isofenoxacin, isoxaflutole, isopyram, isothiazamide, dimethomorph, chlorfluazamide, metalaxyl, metalaxyl-M (metalaxyl-M), methyltetraproline, fluoxazinyl acetophenone, fluoxazin aniline, phosphite (phosphonate), tetrazolium pyridaben, prothioconazole, fluoxazinyl hydroxylamine, azoxystrobin, quinoline, fluoxazinamide, thiophanate-methyl, streptomycin, tebuconazole, flucyanfenoxam, thiamethoxam, triflumethoprim, tebuconazole, benzyl benzoate, N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl [-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]- [1,3-Dimethyl-Butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide and N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide.

12. The antifungal composition according to any one of the preceding claims, wherein, The composition further comprises an agriculturally acceptable carrier, and optionally a surfactant and / or formulation aid.

13. A method for controlling or preventing plant pathogenic diseases, particularly plant pathogenic fungi, on useful plants or their propagation material, the method comprising applying a fungicidal composition as defined in any one of claims 1 to 12 to the useful plants, their sites, or their propagation material.

14. The method according to claim 13, wherein, These components (A) and (B) are applied in sequence.

15. A compound having the formula (XXI) Where A is CH or N; R 2a Selected from H, C 1-6 Alkyl, C 3-6 cycloalkyl and C 1-6 Alkoxy-C 1-6 alkyl; R 2b Selected from H, CN, C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino and -NHC(O)C 1-6 alkyl; R 2c It is H; R 6 Selected from C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 cycloalkyl, C 1-6 Alkylamino, C 1-6 alkoxyamino and C 1-6 Alkyl C 1-6 alkoxyamino; and X is chlorine (Cl), bromine (Br), or iodine (I); Or its salts or N-oxides.

Images